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The results demonstrated that aged rats fed with the control diet organelles, and oxidative stress secondary to uptake and sequestration showed impaired performance on the water maze compared to the of DA. The intracellular ubiquitin-dependent proteasome system and young rats. Furthermore, the diet enriched with spirulina rescued the lysosome-associated autophagy work in partnership to degrade properformance deficit found in aged rats on the control diet. There was teins and turn over organelles. We analyzed the regional accumulation not a significant difference between young rats fed either diet. The of ubiquitin-positive inclusions and lipofuscin as markers of these sysaged spirulina-fed rats' performance was not different from the young tems, respectively. Intranuclear ubiquitin-positive inclusions (Marinerats. The results indicate that a diet supplemented with spirulina can sco bodies, MB) accumulated in TH+ neurons of the vulnerable vtSN improve the age-related deficit in learning and memory as assessed by and staining for TH in TH+ MB vtSN neurons declined prematurely the Morris water maze. While further work is necessary, it appears in middle age. In contrast, TH+ lipofuscin neurons were found primarthat spirulina may be beneficial as a therapeutic agent for an aging ily in the resistant dtSN and VTA. The results are consistent with the population to improve learning and memory. view that defective protein degradation associated with the proteasome This work was supported by the National Institutes of Health system may contribute to degeneration of neurons in vtSN, while ac-(AG04418, AG024165A, MH070430,) and the VA Medical Research tive/excessive autophagy associated with the lysosome system may Service. contribute to resistance to degeneration in dtSN and VTA. In a second study, we analyzed the regional accumulation of 3-nitrotyrosine (3NT) as a marker of oxidative/nitrative damage and intensity of staining Mesencephalic Astrocyte-Derived Neurotrophic Factor (MANF) for the DA transporter (DAT) and vesicular monoamine transporter Reduces Ischemia-Induced Infarction Volume in Rats (VMAT2). Cell counts revealed that the percentage of TH+ neurons accumulating 3NT significantly increased with advancing age in vtSN.
M. Airavaara,* H. Shen,* J. Peränen, † M. Saarma, † Y. Wang,* Advancing age was associated with a significant decline in DAT stainand B. Hoffer* ing only in dtSN. Staining for VMAT2 showed no statistical change with age. Thus, with advancing age, staining for DAT and VMAT2 remained the highest in the vulnerable vtSN and was associated with *National Institute on Drug Abuse, I.R.P., Baltimore, MD, USA the highest percentage of DA neurons accumulating 3NT. We suggest †Institute of Biotechnology, Viikki Biocenter, University of Helsinki, that specific cellular mechanisms impacting degeneration are common Finland to both aging and PD, exist along a continuum, and with exaggeration by additional genetic predispositions and/or insults result in the ex-It has been suggested that MANF (also known as ARMET: argipression of PD.
nine-rich, mutated in early stage of tumors) is a neurotrophic factor, Supported by AG17092 and the Millennium Scholars fund at Uniwhich supports the survival of embryonic mecencephalic dopamine versity of Cincinnati.
neurons in vitro. The effects of MANF have not been studied yet in vivo. MANF and conserved dopamine neurotrophic factor (CDNF) Spirulina Improves Age-Related Deficits in Learning form a novel evolutionary conserved protein family. In the brain and Memory MANF is highly expressed in the hippocampus and cortex. The aim of the present study was to determine whether MANF has a neuroprotective effect in a rat stroke model. Recombinant MANF protein (12 S. A. Acosta,* † A. D. Bachstetter,* † J. Vila,* † M. Pabon,* C. Hudson,* ‡ M. J. Cole,* C. Gemma,* † ‡ and P. C. Bickford* † ‡ µg) or vehicle was administered intracranially into three cortical sites.
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ABSTRACTS Two microliters of MANF solution (2 µg/µl) or PBS was injected and pattern of HuNu and specific neuronal phenotypic expression were consistently observed in 180k and 90k BSMC transplanted stroke ani-allowed to diffuse for 5 min prior to needle removal. After the last injection the right middle cerebral artery (MCA) and bilateral common mals, but not seen in vehicle-infused stroke animals. Moreover, an obvious reduction in ischemic cell loss was recognized in both groups carotids (CCA) were ligated. After 60 min of ischemia the suture around the MCA and arterial clips on CCAs were removed. Animals of transplanted stroke animals compared to vehicle-infused stroke animals. The present study demonstrates the neurorestorative effects of were killed 48 h later. Brains were removed and sliced into 2-mmthick coronal sections for triphenyl-tetrazolium chloride staining. Us-Notch-induced human BMSC grafts in an ischemic stroke model, suggesting the potential of this cell therapy for patients presenting with ing a two-way ANOVA analysis, we found that administration of MANF significantly reduced the cerebral infarction. Post hoc analysis fixed subcortical and cortical infarcts. indicates that the protection of MANF is mainly in the rostral cortical areas. The infarction volume was significantly smaller in the first and second brain slices of the MANF-treated rats compared with vehicle-Differentiation of Telencephalic Neural Progenitor Cells From treated animals. In addition, the area of the largest infarction in a slice Human Embryonic Stem Cells was found to be larger in PBS-treated rats (17 ± 1 mm 2 ) compared Intravascular delivery of neural precursor cells (NPCs) for the The existence of stem cells in the adult mammalian CNS and the ability to isolate and expand them ex vivo provides a number of thera-treatment of stroke requires transendothelial and subsequent intraparenchymal migration. Ischemic brain injury is accompanied by an inflam-peutic opportunities when it comes to treating trauma and degenerative disorders. Along with manipulating endogenous stem cells and their matory response, and associated with formation of a chemoattractant gradient for leukocyte influx. Monocyte chemoattractant protein-1 progeny, which line the ventricular system, transplantation of expanded stem and progenitor cells has shown promising results to im-(MCP-1) is produced by astrocytes, microglia, and endothelial cells via NF-κB signaling in response to prove functional recovery in experimental models of injury and degeneration. However, implementation of this technology requires not only studies have shown that NPCs migrate in response to MCP-1 in a dose-dependent manner. Given the known expression of the MCP-1 standardization to expand the cells in vitro but also development of methodologies to identify distinct population of cells within the het-receptor, CCR2, by NPCs, we hypothesize that the MCP-1/CCR2 interaction constitutes an important step in the recruitment of intravas-erogeneous population of stem and progenitor cells. The ability to manipulate and to pick and choose the donor cell population may well be cularly delivered NPCs after stroke. Using a distal MCA occlusion experimental stroke model in C57/Bl6 mice, we found that intraparen-a key element to successful application of stem cell transplantation therapy. Here we present data on the development of a methodology chymal transplantation of GFP-labeled NPCs derived from CCR2 k/o mice 72 hours after stroke showed significantly impaired migration to to isolate highly purified populations of neurons from neurosphere cultures. Passaged fetal neurospheres were plated at high density (100,000 the ischemic brain area compared to NPCs derived from wild-type littermates and cells from the C17.2 NPC line, which served as posi-cells/ml) in a growth factor serum-containing medium, resulting in the production of at least two distinct cell populations: glial fibrilliary tive controls (p < 0.05, n = 12 per group). Correspondingly, injection of CCR2 k/o NPCs into the ipsilateral internal carotid artery 24 h after acidic protein-immunoreactive (GFAP-IR) astrocytic like cells and a distinct population of non-GFAP-IR cells that express neuronal anti-stroke resulted in significantly lower numbers of GFP-positive cells in the penumbral area compared to cells derived from wild-type litter-gens (Scheffler et al., 2005) . Using flow cytometry, we have exploited the distinct morphology characteristics of these cells to isolate an en-mates (p < 0.05, n = 8 per group). In conclusion, the MCP-1/CCR2 interaction is critically involved in transendothelial recruitment and riched population of immature neurons, resulting in a highly enriched neuronal population (75%). The addition of a positive sorting criterion subsequent targeted migration of NPCs in response to ischemic stroke. Influencing the expression of CCR2 on NPCs might therefore offer (PSA-NCAM-IR), together with morphological characteristics, allowed us to obtain a nearly pure immature neuronal population (97%). new ways for improving intravascular cell replacement approaches after stroke.
Furthermore, the purified neurons exhibit neuronal characteristics in vitro and in vivo following transplantation. The application of technologies to obtain defined populations of progenitor cells from renewable Long-Term Survival of Functional Fetal Dopamine Cell populations of cells, such as neural stem cells, should provide a reli-Suspension Transplants in Parkinson's Disease able cellular source for drug discovery and transplantation strategies. Florida, Tampa, FL, USA functional benefits but also side effects in some patients with Parkin- ‡Honors College, University of South Florida, Tampa, FL, USA son's disease. We have previously reported postmortem analysis of two patients receiving grafted fetal VM cell suspensions and surviving §James A. Haley VA Hospital, Tampa, FL, USA up to 4 years posttransplantation, with clinical benefits and no side effects (Mendez, I., et al., 2005) . We now present a postmortem analy-Adult stem cells are present in many tissues, including skin, mussis of cell suspension grafts of an additional two patients surviving for cle, adipose, bone marrow, and, importantly, in the brain. With aging 9 years posttransplantation. Fetal ventral midbrain tissue, obtained a process of cellular senescence occurs that limits the regenerative from elective abortions, and prepared as a cell suspension, was stereoability of these stem cell pools. Neuroinflammation has been shown taxically injected into the putamen of patients with idiopathic Parkinto be a potent negative regulator of stem cell and progenitor cell prolifson's disease. Postmortem analysis was performed with immunohistoeration in the neurogenic regions of the brain. Recently, we demonchemistry and stereological procedures on two patients that died of strated that decreasing a key neuroinflammatory cytokine IL-1β in the unrelated causes 9 years after transplantation. Both patients had a fahippocampus of aged rats reversed the age-related cognitive decline vorable clinical course after transplantation without motor complicaand increased neurogenesis in the age rats. We also have found that tions. PET scans were indicative of graft survival. Immunostainings nutraceuticals have the potential to reduce neuroinflammation and defor tyrosine hydroxylase (TH) revealed surviving grafts with reincrease oxidative stress. Spirulina, a blue-green algae that has antioxinervation in both patients. The long-term survival of grafted dopamine dant and anti-inflammatory properties, was shown to be the most efneurons and lack of side effects in these two patients is encouraging.
fective of a number of nutraceuticals tested, and has recently be shown to improve learning in aged rats. The objective of this study was to determine if spirulina could protect the proliferative potential of hippo-Purification of Neurons From Neural Stem Cells campal neural progenitor cells from an acute systemic inflammatory insult of lipopolysaccharide (LPS). To this end, young rats were fed H. Azari,* † G. Osborne,* B. Scheffler, ‡ D. Steindler, ‡ for 30 days a control diet or a diet supplemented with 0.1% spirulina. and B. A. Reynolds* ‡ On day 31 the rats were given a single IP injection of LPS (1 mg/kg).
The following day the rats were injected with BrdU (50 mg/kg, b.i.d., *Queensland Brain Institute, Brisbane, Australia IP) and were sacrificed 24 h after the first injection of BrdU. Quantifi- †Medical University of Isfahan, Isfahan, Iran cation of the BrdU-positive cells in the subgranular zone of the dentate ‡McKnight Brain Institute, University of Florida, gyrus demonstrated a decrease in proliferation of the stem/progenitor cells in the hippocampus as a result of the LPS insult. Furthermore, the Gainesville, FL, USA 460 ABSTRACTS diet supplemented with spirulina was able to negate the LPS-induced demonstrated threefold increased spontaneous autorosette formation and twofold elevated active E-rosette-forming cells compared to ALS decrease in stem/progenitor cell proliferation. These results support the hypothesis that a diet enriched with spirulina may help protect the patients with moderate stage of disease (group 2). While further investigation is needed to determine which T-lymphocyte subset is involved stem/progenitor cells from the negative effects of inflammation.
This work was supported by the National Institutes of Health in this reaction, these initial results suggest that autorosette formation may be useful as a simple biological marker for the progression of ALS. (AG024165A, AG04418) and the VA Medical Research Service.
Supported by Saneron CCEL Therapeutics, Inc. S.G.D. and A.E.W. are We are continuing to investigate if these represent simple cell death from shock of transplantation or rejection by the host. Amyotrophic lateral sclerosis (ALS) is a fatal motor neuron disease without identifiable biomarkers of disease progression or effective therapy. Increasing evidence points to immune system involvement in ALS. Little data exist on the immune system status as ALS rAAV-AADC Gene Transfer for Parkinson's Disease progresses. Significant lymphopenia and an increased CD4/CD8 ratio have been noted in ALS patients even at early stage disease and, ac-K. Bankiewicz, J. L. Eberling, C. W. Christine, J. Forsayeth, companied by spontaneous rosette formation with autologous erythro-P. Starr, P. Larson, W. J. Jagust, and M. J. Aminoff cytes, was also found at terminal stage of disease in mice modeling ALS (Kuzmenok et al., 2005) . We hypothesized that immune system University of California at San Francisco, San Francisco, CA, USA response in ALS changes during disease course and that this response depends on lymphocyte function. The aim of this study was to evaluate lymphocyte function by E-rosette formation in the peripheral blood of The main medication for idiopathic Parkinson disease is L-dopa. Drug efficacy declines steadily in part because the converting enzyme, ALS patients at different stages of disease. Peripheral Blood (PB) was obtained from 12 ALS patients and 5 healthy volunteers. Complete aromatic L-amino acid decarboxylase (AADC), is lost concomitant with substantia nigra atrophy. Dopamine, the major neurotransmitter blood counts (CBCs), including white blood cell differential (WBCD), were performed. Blood smears were stained with Giemsa. Pictures depleted in Parkinson disease, can be synthesized and regulated in vivo with a combination of intrastriatal AAV-hAADC gene therapy were taken from various areas of each slide and the percentage of spontaneous autologous E-rosettes calculated. Immunohistochemical and administration of the dopamine precursor L-dopa. When tested in MPTP-lesioned monkeys, this approach resulted in long-term im-staining for CD2 was also performed. In another experiment, mononuclear cells from PB (MNC PB) of ALS patients and healthy volunteers provement in clinical rating scores, significantly lowered L-dopa requirements, and a reduction in L-dopa-induced side effects. Positron were isolated and incubated with sheep erythrocytes at a ratio of 1:20 in Hank's solution. Active and total rosette-forming cells were counted emission tomography with [ 18 F]FMT confirmed persistent AADC activity, demonstrating for the first time that infusion of AAV vector after 30-and 90-min incubation, respectively. Eight ALS patients (group 1, ALSFRS 19.9 ± 1.04) had autologous E-rosette formation into primate brain results in at least 8 years of transgene expression. The relationship between vector dose and a series of efficacy markers, with lymphocytes (3.7 ± 1.49%) and neutrophils (11.4 ± 1.29%). Four ALS patients (group 2, ALSFRS 32.5 ± 1.20) had E-rosette formation such as PET, L-dopa response, and AADC enzymatic activity was also established. At low doses of vector, no effect of vector was seen on with lymphocytes (1.0 ± 0.67%) and neutrophils (7.8 ± 2.16%). In five healthy volunteers (ALSFRS 48), there was no spontaneous E-rosette PET or behavioral response. At higher doses, a sharp improvement in both parameters was observed, resulting in an approximate 50% formation with lymphocytes and only two had neutrophil E-rosettes of 1.3% and 2.2%. CD2+ cells were found in group 1 (1.98 ± 0.57), improvement in L-dopa responsiveness. The relationship between vector dose and AADC enzymatic activity in tissue extracts was linear. group 2 (0.95 ± 0.35), and healthy volunteers (0.38 ± 0.16). Active Erosette forming cells were: Group 1-40.5 ± 7.16%, group 2-21.4 ± We conclude that little behavioral improvement can be seen until AADC activity reaches a level that is no longer rate limiting for con-12.19%, control-33.4 ± 5.40%. Numbers of total E-rosette-forming cells were similar in ALS patients and healthy volunteers. CBCs and version of clinical doses of L-dopa into dopamine or for trapping of the PET tracer FMT. AAV-hAADC restores the ability of the striatum WBCD correlated with the number of spontaneous autologous and induced E-rosette-forming cells in patients. Results show that ALS pa-to convert L-dopa into dopamine efficiently. These findings have implications for the design and interpretation of clinical studies of AAV-tients diverge in lymphocyte functionality, possibly due to differences in immune system response. Patients most severely affected (group 1) hAADC gene therapy. Introduction of this therapy into the clinic holds promise for Parkinson patients experiencing the motor complications †Institute of Molecular Genetics, Academy of Sciences of Czech that result from escalating L-dopa requirements against a background Republic, Prague, Czech Republic of disease progression. To evaluate safety and early efficacy of AAV- ‡Department of Normal, Pathological and Clinical Physiology, hAADC, gene delivery into the striatum of patients with Parkinson's Charles University Prague, Czech Republic disease was initiated at UCSF. Patients with moderate to advanced PD §Institute of Histology and Embryology, First Faculty of Medicine, received bilateral infusions of a low or high dose of the AAV-AADC Charles University Prague, Czech Republic vector into the putamen using convection-enhanced delivery method. Positron emission tomography (PET) and the AADC tracer (FMT) In the presented study we have been testing the effect of therapeuwere evaluated at baseline 1, 6, and 12 months posttreatment. Results tic angiogenesis using plasmid transfer of cDNA VEGF (phVEGF) obtained so far will be presented. and pNGF in experimental spinal cord injury. In this context, experiments were designed in order to determine the potential of phVEGF A Peptide From Tarantula Venom Enhances NGF-Induced and pNGF to augment the angiogenesis in traumatic tissue and to facil-Neurite Production in Dopaminergic PC12 Cells itate regeneration, and functional recovery eventually. The expression pattern and optimal dosing of administered plasmid DNA were tested T. A. Barone,* P. A. Gottlieb, † Y. K. Murphy, † F. Sachs, † on skin and cartilage trauma in BALB/c mouse strain. According to and R. J. Plunkett* ‡ the results obtained from these observations, the dosing in rat neural trauma was designed. A modification of a balloon compression technique to produce spinal cord injury in adult rats (Wistar) was used. A *Department of Neurosurgery, Roswell Park Cancer Institute, 2-French Fogarty catheter was inserted into the dorsal epidural space Buffalo, NY, USA through a small hole made in T10 vertebral arch, advanced cranially †Department of Physiology and Biophysics, SUNY at Buffalo, to T8-9 spinal level, and inflated for 5 min continually. Spinal cord Buffalo, NY, USA damage was graded by increasing the volume (up to 15 µl) of saline ‡Department of Neurosurgery, SUNY at Buffalo, Buffalo, NY, USA used to inflate the balloon. Following rat spinal cord paraffin-embedded tissue samples with and without plasmid DNA administration GsMTx4, a peptide isolated from the venom of a tarantula, Gramwere analyzed morphologically, immunohistochemically, and by qRTmostola spatulata, is the only known pharmacological agent to specifi-PCR to characterize the injury and the plasmid expression pattern cally inhibit nonselective cationic mechanosensitive ion channels along the whole thoracic part of the spinal cord on days 3, 7, and 21. found in nonspecialized eukaryotic tissues. GsMTx4 is nontoxic
The VEGF expression was, at first glance, higher in the sections taken (Bowman et al., Toxicon 49; 2007) and is thought to have beneficial from experimental pinnae at days 1, 3, 5, 7, 9, 11, 13, 15, and 30 . In therapeutic affects as it blocks atrial fibrillation in heart tissue (Bode phVEGF-administered pinnae a higher degree of angiogenesis, demonet al., Nature 409; 2001) . Recently, Jacques-Fricke et al. (J. Neurosci. strated with more numerous vessels appearing in granulation tissue, 26; 2006) demonstrated that GsMTx4 stimulates neurite growth by was observable from days 3 to 7. The difference of VEGF expression inhibiting local Ca 2+ influx in Xenopus embryo spinal cord explants between experimental and control material disappeared at day 9. Conover a 30-min observation period. We sought to determine whether sidering the results in pinnae experiments the VEGF and NGF (c = the peptide had neurite-promoting effects on dopaminergic cells. PC12 100 ng/µl in volume of 15-50 µl) was administered into the spinal cells were plated at 4 × 10 4 cells/well in a 24-well plate and allowed cord immediately after contusion through the injection into the T8-9 to attach for 24 h. In a pilot experiment, cells were treated with either part, reaching the white matter of the spinal cord. Similarly, a saline 5 µM GsMTx4, 50 ng/ml nerve growth factor (NGF), or PBS control solution was injected to the control rats undergoing the same spinal and compared at 1, 6, 24, and 48 h. By 6 h, cells treated with GsMTx4 cord contusion surgery. The obtained results showed differences beappeared to have more neurites per cell and a higher percentage of tween the control and injured rats not only in the increased VEGF cells bearing neurites than the PBS control, but not more than NGFexpression, but in the morphology of the injured cells. Faster recovery treated cells. By 24 h, GsMTx4-initiated neurites seemed to degrade has been confirmed comparing the morphology of the samples on day as there was no difference between GsMTx4 treated and PBS control.
7. Better results have been obtained when both VEGF and NGF have These results prompted us to determine if GsMTx4 would offer a synbeen administered. Further behavioral testing follows. ergistic effect with NGF. Attached cells were treated simultaneously with 50 ng/ml NGF and 5 µM GsMTx4 and compared to NGF alone or untreated cells. After 24 h, cells treated with the combination of GsMTx4 and NGF had a greater percentage of cells bearing neurites Minocycline Restores Striatal Tyrosine Hydroxylase and Nigral than NGF alone, as determined by a blinded observer. In a concentraphospho-ERK in GDNF Heterozygous Mice tion study of GsMTx4 (5 nM-50 µM) with 50 ng/ml NGF, we observed a marked increase in percentage of neurite-bearing cells, over H. A. Boger and A.-C. Granholm NGF alone, starting at the 5 µM concentration. GsMTx4 concentrations of 5 and 50 µM resulted in a 53% and an 80% increase, respec-Department of Neurosciences and the Center on Aging, Medical tively, with an average of 105 cells analyzed per treatment group. Pre-University of South Carolina, Charleston, SC, USA liminary comparison by ANOVA, with Tukey's post hoc analysis, reveals only the 50 µM concentration to offer a statistically significant Inflammation and activation of the phospho-p38 MAPK pathway benefit. Analysis of additional images is ongoing. These results suggest have been implicated in the pathology of several neurodegenerative that GsMTx4 enhances neurite initiation and may provide a therapeutic diseases, including Parkinson's disease (PD). Inflammation is thought approach in which synergy between GsMTx4 and other neurotrophic to contribute to the supply of neurotrophic factors, including glial cell factors will foster axonal initiation and extension in neurodegenerative line-derived neurotrophic factor (GDNF), by increasing the expresdiseases such as Parkinson's disease. sion/excretion from activated microglia and astrocytes. In a previous This research was supported by a grant from NHLBI to F.S. study from our laboratory, mice with a partial deletion of GDNF (GDNF +/− ) displayed increased microglial activation in the substantia Regeneration of the Intraspinal Plasticity Induced by VEGF nigra (SN) at 3 months of age. Furthermore, GDNF has been shown and NGF Plasmid to exert protective effects on the dopamine system in vitro by way of various signaling pathways, including ERK/MAPK, PI3K, and PLCγ, V. Bobek,* K. Kolostova,* D. Pinterova,* M. Boubelík,* † but conclusive studies have not been performed on GDNF signaling O. Raška, ‡ R. Rokyta, ‡ and M. Jirkovská § in situ. Therefore, the purpose of this study was to assess potential restorative effects of minocycline, a second derivative tetracycline, on *Department of Tumor Biology, Third Faculty of Medicine, Charles genetically induced microglial activation and GDNF-related neuronal signaling. At 2.5 months of age, wild-type (WT) and GDNF +/− mice University Prague, Czech Republic 462 ABSTRACTS were administered either saline or minocycline (45 mg/kg, IP) for 14
Evaluating the Cell Dose and Graft Recipient Gender Effects Over an Extended Period After Intravenous Transplantation days. This study revealed that 3-month-old saline-treated GDNF +/− mice had increased microglial activation, increased phospho-p38 of Bone Marrow-Derived Multipotent Adult Progenitor Cells in Experimentally Induced Stroke in Adult Rats MAPK, and decreased phospho-ERK compared to saline-treated WT mice in the SN. Minocycline treatment resulted in a decrease in microglial activation and phospho-p38 MAPK, as well as an increase in C. V. Borlongan,* † T. Yasuhara,* K. Hara,* M. Maki,* T. Masuda,* phospho-ERK immunohistochemistry in the SN of GDNF +/− mice. In S. J. Yu,* M. Ali,* R. W. Mays, ‡ R. J. Deans, ‡ J. E. Carroll,* † terms of tyrosine hydroxylase immunoreactivity (TH-ir) in the striaand D. C. Hess* † tum, a 14-day regimen of minocycline resulted in increased TH-ir levels in GDNF +/− mice compared to saline-treated GDNF +/− mice. These *Department of Neurology, Medical College of Georgia, Augusta, data suggest that GDNF exerts effects in DAergic neurons via the GA, USA ERK/MAPK pathway, and also that activation of the p38 MAPK path- †Research & Affiliations Service Line, Augusta VAMC, GA, USA way is a major player in the deficits observed in mice with a partial ‡Regenerative Medicine, Athersys, Inc., Cleveland, OH, USA loss of GDNF.
This work was supported by NIH Grant AG023630.
To extend our initial observation of therapeutic benefits of intravenous (IV) human bone marrow-derived multipotent adult progenitor cells (MAPC) 14 posttransplantation (earliest testing period) and progressively im-Transplantation, CHU, Nantes, France proved over time up to day 56 posttransplantation (a subset of animals are still being tested at longer periods), except with the 400k dose, ¶Université de Nantes, Faculté de Médecine, Nantes, France which only partially ameliorated the stroke-induced behavioral deficits #Université de Nantes, UFR des Sciences et des Techniques, Nantes, and appeared to revert to negative control impairment levels. Two France clusters of behavioral effects were seen with 1 million and 2 million **Universitie de Nantes, Nantes, France showing comparable benefits, and with 4 million, 10 million, and 20 million exerting the most robust improvement. These dose-dependent Huntington's disease (HD) is genetic disorder that leads to dysand clustering effects were apparent in both male and female rats with function and death of neurons, producing progressive motor, cognitive, no detectable gender differences. Histological examination is currently and psychiatric deficits. Although no effective treatments are currently under way. We demonstrate that 4 million IV MAPC corresponds to available, research by Martinez-Serrano and Bjorklund (J. Neurosci. a critical therapeutic dose that allows improvement in both motor and 16:4604-4616) has indicated that altering neural stem cells to overexneurologic function in both male and female stroke rats over an express nerve growth factor (NGF) and brain-derived neurotrophic factor tended period posttransplantation. (BDNF) can reduce cell death in the quinolinic acid rat model of HD.
This study is supported by NIH NINDS UO1 UNS055914A. C.V.B., The present study attempted to extend these findings by examining J.E.C., and D.C.H. are also supported by an Athersys Research Grant. whether altering bone marrow stem cells (BMSC) to overexpress NGF and BDNF would confer behavioral benefits in the yeast artificial chromosome (YAC) 128 transgenic mouse model of HD. Bone mar-Increased Gene Expression of Neprilysin Using AAV row was extracted from the femurs of mice, transgenic for green fluoand Convection-Enhanced Delivery Decreases ␤-Amyloid rescent protein (GFP). The cells were cultured, passaged twice, and Load in APP ؉ PS1 Mice transfected via murine stem cell virus vectors containing genes that constitutively express BDNF or NGF. The cells were further isolated via magnetic cell sorting using anti-mouse Ly-6A/E (Sca-1) and their N. Carty,* M. Mercer,* C. Meyers, † K. Nash, † N. Muzyckza, † M. N. Gordon,* and D. Morgan* transfection was confirmed via polymerase chain reaction and enzymelinked immunoabsorbent assay. Results indicated that all YAC mice showed significant behavioral deficits, relative to wild-type mice, but of the YAC mice, those given
The accumulation of β-amyloid peptides in the brain has been recognized as an essential factor in Alzheimer's disease (AD) pathology. BDNF/BMSC transplants had the fewest behavioral deficits, whereas all other groups showed only modest or no reductions in deficits, rela-Recently, it has been argued that concentrations of Aβ can be modulated by several endogenous zinc metallopeptidases or β-amyloid de-tive to vehicle-treated YAC mice. These findings indicate that delivery of BDNF via BMSC may provide a potentially efficacious treatment grading enzymes. Gene therapy using adeno-associated viral (AAV) vectors is an effective means of delivering transgene encoding for strategy for HD. these specific proteases, which include neprilysin, ECE, and IDE to chemokines into the periphery that attract peripheral immune mediators to the sites of inflammation. Immune mediators enter the brain regions in the brain affected by AD pathology. A disadvantage of typical intracranial administration into the parenchyma is a limited distri-more readily because of the BBB breakdown where they contribute to further dopamine neuron loss, producing disease progression. If this bution of the AAV macromolecules to all regions within the brain where therapies may be needed. Convection-enhanced delivery (CED) hypothesis is correct, then new therapies for PD could involve the use of drugs that repair the BBB (e.g., drugs that increase cAMP in endo-is a method of delivering clinically relevant volumes of therapeutic agents to significantly larger areas by utilizing the phenomenon of thelial cells), drugs that modulate immune cell entry [e.g., selective adhesion molecule (SAM) inhibitors; natalizumab] or sphingosine-1-positive pressure to increase distribution of macromolecules within solid tissue. In this study, the convection-enhanced delivery method phosphate (S1P) receptor agonists (FTY720) that reduce autoreactive T cells. Identification of the specific chemokines released by dopamine using the step-design cannula (Bankiewicz, 2005) was used to deliver adeno-associated viral vectors expressing either a native form of hu-degeneration would facilitate the development of specific antagonists. These strategies are not likely to prevent the initial degenerative pro-man neprilysin (NEP-n) gene or an engineered secreted form of neprilysin (NEP-s) gene into the right hippocampus and right cortical re-cess (e.g., MPTP or 6-OHDA models), but rather prevent progressive neuron loss once a model for this element of PD is developed. gions of the mouse brain. The control group was treated with a rAAV vector expressing a mutant neprilysin (NEP-m) gene product with a single point mutation in the active site, rendering it inactive. After 6 weeks histology was performed to measure NEP gene expression and PTEN Deletion During Development Causes Hypertrophy distribution. Immunohistochemistry for NEP revealed strong expresand Increased Proliferation of Dopaminergic Neurons sion throughout the hippocampus in animals treated with the NEP-n in the Ventral Mesencephalon: Does the Dopaminergic System and NEP-m vectors. Animals treated with the NEP-s showed similar Remain Functional During the Mouse Lifespan? results but expression was seen in a smaller area within the hippocampus compared to the NEP-n-treated group. Immunohistochemistry for O. Diaz-Ruiz, Y. Zhang, L. Shan, N. Malik, B. Harvey, A. Zapata, total Aβ was significantly decreased in animals receiving the NEP-n B. J. Hoffer, A. C. Tomac, and C. M. Bäckman and NEP-s viral vectors when compared to control animals in both the hippocampus and cortex. Congo red staining followed a similar trend, Cellular Neurobiology Branch, National Institute on Drug Abuse, revealing significant decreases in the hippocampal fissure and CA1 National Institutes of Health, Baltimore, MD, USA regions and the cortex for NEP-n and NEP-s treatment groups compared to control. These data suggest that increasing the expression of
The widespread distribution of the tumor suppressor PTEN (for certain endogenous β-amyloid degrading enzymes through gene ther-"phosphatase and tensin homologue deleted from chromosome ten") apy using the CED step cannula provides an efficient means of inin the adult and developing brain suggests its role in a broad range of creasing transgene distribution and ultimately may provide a promisbrain functions. The PTEN tumor suppressor negatively regulates the ing therapeutic avenue through which to treat AD.
PIK3 signaling pathway, thereby regulating signals for growth, prolif-Supported by AG 25509. eration, and cell survival. Deletion of PTEN in the mouse brain has revealed its role in controlling cell size and number. In this study, we used the Cre-loxP technology to selectively inactivate PTEN in cells The Autoimmune Hypothesis of Parkinson's Disease expressing the dopamine transporter. The resulting mutant mice showed neuronal hypertrophy, and an increased number of dopaminergic neu-P. M. Carvey* and A. Monahan † rons and fibers in the substantia nigra (SN) and ventral tegmental area (VTA). Interestingly, several landmarks that characterize the dopamin-*Department of Neurological Sciences, Rush University Medical ergic projection to the striatum were not altered in these mutant mice. Center, Chicago, IL, USA Striatal enkephalin, dynorphin, DRD1 and DRD2 mRNA levels re- †Department of Pharmacology, Rush University Medical Center, mained similar to those of control animals. In addition, total dopamine Chicago, IL, USA levels in the dorsal striatum of adult animals were similar between control and mutant mice, while they were significantly elevated in the ventral midbrain. Preliminary results showed no significant differences We previously demonstrated that animal models of Parkinson's in potassium-evoked dopamine release in the striatum between the disease (PD), as well as autopsy tissues from patients with PD, exhibgroups. No significant differences were found in baseline and cocaineited evidence of BBB dysfunction. This dysfunction appeared to result induced locomotor activity in mutant animals at 3 and 12 months of from microglia-associated neuroinflammatory processes. We showed, age. The results presented here show that inactivation of PTEN or as have others, that this dysfunction had functional consequences inmanipulation of the Akt signaling pathway during development including increased entry of drugs from the peripheral vasculature. Recreases the number and size of dopamine neurons present in the SN cent pilot studies from our laboratory as well others also demonstrated and VTA, and that the PTEN-deficient dopaminergic system remains increased entry of T cells into brain, suggesting the involvement of functional during the life span of the mutant mice. These results proimmune-mediated events in the disease process. We originally hypothvide further evidence about the role of PTEN in dopaminergic neurons esized an autoimmune component in PD in 1991 (Neurology 41-S2: and suggest that manipulation of the PTEN/Akt signaling pathway 53-60; 1991) based on our ability to predict patients with and without may provide a therapeutic strategy for the treatment of Parkinson's PD using IgG isolated from CSF. We argued that the release of endisease and other neurodegenerative disorders. crypted antigens produced by the degenerative process became immu-Research supported by the IRP of NIDA, NIH, DHHS. nogenic, and the subsequent development of an antibody-mediated response led to an autoimmune response that would perpetuate the disease process-produce disease progression. At that time, the brain was considered an immune privileged organ. However, today we know that A. Ducray, R. W. Seiler, and H. R. Widmer suggested that it was not the release of encrypted antigen, but rather that normal proteins altered by the disease process (i.e., free radical Department of Neurosurgery, Bern University Hospital attack) become immunogenic. We therefore hypothesis that the neuand University of Bern, Bern, Switzerland roinflammation accompanying dopamine neuron degeneration leads to focal breakdown in the BBB and the release of inflammation altered proteins (AIPs) that become immunogenic after they escape from brain Various growth factors are known to influence the development, survival, and differentiation of cultured dopaminergic neurons from parenchyma. The BBB breakdown enables release of brain-derived 464 ABSTRACTS the ventral mesencephalon (VM). Detailed knowledge about the ef-may be used as physiological assays in early phase trials of experimental therapies for PD and other neurodegenerative disease. fects of these neurotrophic factors on subpopulations of midbrain dopaminergic neurons is essential for their potential application as therapeutic molecules for Parkinson's disease and for their role during development of the VM. So we have previously shown that glial cell Endogenous Production of a Primitive CD34 + Hematopoietic line-derived neurotrophic factor promoted differentiation of dopamin-Stem Population Is Increased in Pregnant and Parous Women ergic and nondopaminergic calretinin-expressing neurons in cultured VM (Schaller et al., Brain Research 1036:163-172; 2005) . Interest-N. El-Badri (Dajani),* M. Manion, † C. Szekeres, ‡ and M. Groer † ingly, it has been reported that some neurons in the VM of adult rats coexpress the neurotransmitters dopamine and GABA. Moreover, in *Center of Excellence for Aging and Brain Repair, Department cultured neuroblasts colocalization of the dopaminergic marker tyroof Neurosurgery, College of Medicine, University of South Florida, sine hydroxylase (TH) with GABA and choline acetyl transferase has been described. The present study investigated by means of colocaliza-Tampa, FL, USA tion analyses for the possible expression of GABA or serotonin (5- †College of Nursing, University of South Florida, Tampa, FL, USA hydroxytryptamine, 5-HT) in TH-immunoreactive (-ir) neurons. For ‡Office of Research, College of Medicine, University of South that purpose E14 fetal rat VM were cultured for up to 8 days in vitro Florida, Tampa, FL, USA (DIV). We first detected that 6%, 30%, and 3.5% of total neuronal number in our cultures at DIV5 were immunoreactive for TH, GABA, Fetal microchimerism refers to the presence of fetal cells in materand 5-HT, respectively. While we did not observe immunoreactivity nal blood and tissues during pregnancy. Physiological changes in the for GABA in TH-ir neurons, we found that 35% of TH-ir neurons also maternal blood cellular milieu are also recognized during pregnancy expressed 5-HT. Importantly, double immunofluorescence for 5-HT and in the early postpartum period. Earlier studies showed that materand TH in VM neurons was also detected in organotypic VM cultures nal blood contains CD34 + hematopoietic stem cells (HSCs) that bear and in expanded and differentiated VM precursor cells. In order to paternal genetic markers or male phenotype, suggesting that these cells further substantiate our observation, colocalizations were performed circulated to the mother from male fetuses during pregnancy. The obusing the specific markers for dopaminergic and serotonergic neurons, jectives of this study are to investigate the effect of pregnancy on the Nurr1 and SERT, respectively. In agreement to the outcome seen for frequency, characteristics, and functions of maternal CD34 + HSCs, and TH and 5-HT, we could demonstrate coexpression of Nurr1 and SERT to determine the origin of these HSCs. Peripheral blood mononuclear in cultured VM neurons. The percentage of TH-ir neurons also excells (PBMC) were collected from pregnant women, parous women, pressing 5-HT was observed to be dependent on time in culture with nuliparous women, and men. PBMCs were isolated by Ficoll density a significant increase from DIV2 (6%) to DIV5 (28%) followed by a centrifugation. The samples were stained with anti-CD3, CD14, CD16, decrease between DIV5 and DIV8 (to 18%). In addition, plating den-CD19, CD20, CD56 fluorescein isothiocynate (FITC) lineage antibody sity affected colocalization rate of TH and 5-HT. So we detected that cocktail. Samples were further stained with anti-CD117 PerCp-Cy5.5, the percentage of TH-ir neurons also expressing 5-HT decreased from CD34 phycoerythrin-Cy7 (Pe-Cy7), anti-CD14 allophycocyanin-Cy7 26% to 9% and 1%, with an initial plating density of 0.5, 0.8, and (APC-Cy7), and anti-SSEA-4 allophycocyanin (APC). Cells were washed 1.25 embryos per well, respectively. Taken together, these observaand subsequently stained with anti-OCT 3/4 phycoerythrin (PE). Data tions illustrate that a subpopulation of cultured rat VM dopaminergic was collected with a FACSAria three-laser (488, 633, 407 nm) cytoneurons does coexpress serotonin. Our finding likely holds impact for meter and analyzed using FlowJo software. A primitive population of studies addressing the potential of neurotrophic factors in inducing CD34 + hematopoietic stem cells that express the embryonic markers a dopaminergic phenotype in neurons derived from undifferentiated Oct4 and SSEA4 can be detected in the peripheral blood of pregnant precursor cell. and postpartum women, but not in nulliparous women or men. Quantitative analysis showed significant increase in CD34 + HSCs in pregnant women compared to mulliparous women and men. A unique subpopulation of these cells was detected only in blood samples from pregnant Modulation of Metabolic Brain Networks After Subthalamic women and expressed the embryonic markers Oct4 and SSEA4. Preg-Gene Therapy for Parkinson's Disease nancy stimulates the increased production of CD34 + HSCs. Expression of embryonic markers on these cells indicates that they maybe of fetal D. Eidelberg* † origin, or alternatively represent a unique population of maternal-derived cells. Ongoing genetic and functional analysis should determine the *Center for Neurosciences, The Feinstein Institute for Medical origin of these cells. This phenomenon could potentially favor postpar-Research, North Shore-Long Island Jewish Health System, tum regenerative capacity. It may also explain the improved course of Manhasset, NY, USA some neurological disorders during pregnancy. †Departments of Neurology and Medicine, New York University School of Medicine, New York, NY, USA Release of VEGF by ReN001 Cortical Stem Cells Parkinson's disease (PD) is characterized by elevated expression of an abnormal metabolic brain network that is reduced by clinically D. J. Eve,* J. Musso, III,* V. H. Bui,* A. J. Smith,* C. Gemma,* effective treatment. We used FDG PET to determine the basis for mo-D. F. Cameron,* † C. Oliveira, ‡ K. Pollock, ‡ A. Hope, ‡ tor improvement in 12 PD patients receiving unilateral subthalamic M.-O. Baradez, ‡ J. D. Sinden, ‡ and P. R. Sanberg* † nucleus (STN) infusion of an adeno-associated virus vector expressing glutamic acid decarboxylase (AAV-GAD). Following gene therapy, *Center of Excellence for Aging and Brain Repair, Department we observed significant reductions in thalamic metabolism on the opof Neurosurgery, University of South Florida College of Medicine, erated side, as well as concurrent metabolic increases in ipsilateral Tampa, FL, USA motor and premotor cortical regions. Abnormal elevations in the activ- †Department of Pathology and Cell Biology, University of South ity of metabolic networks associated with motor and cognitive func-Florida College of Medicine, Tampa, FL, USA tioning in PD patients were evident at baseline. The activity of the ‡ReNeuron Inc., Guildford, England motor-related network declined following surgery and persisted at 1 year. These network changes correlated with improved clinical disability ratings. By contrast, the activity of the cognition-related network Previous research using the human immortalized cortical stem cell line (ReN001; ReNeuron, Inc., UK) revealed considerable benefit on did not change following gene transfer. This suggests that modulation of abnormal network activity underlies the clinical outcome observed long-term transplantation of these cells into the MCAO rat model of stroke. The mode of action does not appear to be by cell replacement, after unilateral STN AAV-GAD gene therapy. Network biomarkers so instead it may be by the release of specific growth factors. These of neural progenitor proliferation by cocaine, comprising a mechanism by which cocaine interferes with brain development. factors could promote angiogenesis and/or neurogenesis, thus promoting the growth of cells in the infarcted area. This was investigated by
Research supported by the IRPs of NIDA and NIA, NIH, DHHS. the use of protein arrays and ELISAs to determine what factors are released by these cells into their media as they grow and proliferate. The cells were grown in their requisite media (replaced every 3 days)
Age-Related Hippocampal Dendritic Loss Is Further Aggravated until greater than 70% confluence was reached. The media were then by Dietary Lipids collected, spun down to remove cell debris, and frozen over methanol and dry ice in 1.5-ml aliquots. The media were biotinylated and run L. Freeman,* C. Stevens, † V. Haley-Zitlin, † A. Moore,* on a RayBio Biotin Label-based Human Antibody Array, which can and A.-C. Granholm* † determine up to 507 specific human proteins. Media collected at several different passages and over 1, 2, or 3 days were processed in this *Department of Neuroscience, Medical University of South Carolina, way and certain proteins were consistently observed, the most interest-Charleston, SC, USA ing being vascular endothelial growth factor (VEGF), a promoter of angiogenesis. This result was confirmed by use of a specific ELISA †Department of Food Science and Human Nutrition, Clemson for human VEGF (R&D Systems) and values ranging from 1 to 3 ng/ University, Clemson, SC, USA ml were detected.Ongoing studies using an in vitro angiogenesis assay, ‡Center on Aging, Medical University of South Carolina, Charleston, in which rat aorta is grown in the conditioned media, have demon-SC, USA strated extensive organized growth of capillary-like structures with conditioned media from these cells (compared with disorganized struc-Numerous factors contribute to age-related cognitive decline intures in unconditioned media), suggesting that the media have the abilcluding genetics, sex hormones, and environment. The focus of this ity to promote angiogenesis. We are currently investigating whether study was to determine the role of a high-fat diet on age-related VEGF is the important factor for this process or whether other factors changes to hippocampal morphology, the primary site for learning and are involved.We have therefore shown that the ReN001 stem cells memory. Previous studies have shown a loss of neurons, overall volrelease VEGF and their conditioned media promotes angiogenesis-like ume, and dendritic integrity in the hippocampus. Here we reveal an activity.
even greater loss of dendrites in the CA1 region of the hippocampus Supported by ReNeuron, Inc.
following a short-term exposure to various high-fat diets. Forty middle-aged male Fischer 344 rats were fed a 12% fat diet for 8 weeks; the animals were randomly divided into four groups and fed the fol-
Inhibition of Neural Progenitor Cell Proliferation by Cocaine
lowing types of lipids: 12% soybean oil, 12% hydrogenated soybean oil, 10% soybean oil + 2% cholesterol, and 12% lard. Map 2 immunohistochemistry of the hippocampus from the right hemisphere of each W. J. These results indicate an important role of †ScienCell Research Laboratories, San Diego, CA, USA diet in age-related hippocampus degeneration even though a biological ‡DNA Array Unit, Research Resources Branch, National Institute mechanism for these findings has not been revealed. With additional on Aging, NIH, DHHS, Baltimore, MD, USA studies, the mechanisms by which these particular lipids affect brain structure and function, an area normally protected by the blood-brain §Developmental Neurobiology Section, Cell Biology and Physiology barrier, can be determined. This will have a major impact on treatment Center, Division of Intramural Research, National Heart, Lung strategies for Alzheimer's disease and other degenerative disorders of and Blood Institute, NIH, DHHS, Bethesda, MD, USA aging, because dietary intake has been found to play a major role in the onset and progression of these severe disorders. Although it is generally recognized that cocaine adversely affects Supported by AG04418, AG12122, AG023055, and AG022103. brain development, the molecular mechanism responsible is unknown. Mechanisms of action involved in the effect of cocaine on neural progenitor cells were therefore explored using a neural progenitor cell Parkinson's Disease Pathology in Nigral Grafts That line (AF5), and verified using primary human brain cell cultures and Are Unrelated Genetically and Immunologically in developing fetal rat brains. Cocaine inhibited proliferation of AF5 to the Transplant Recipient cells by interfering with the G 1 -to-S transition, but did not cause cell death. Using microarray analysis followed by real-time RT-PCR, cyclin A2 was identified as being the cell cycle regulator altered by T. B. Freeman,* Y. Chu, † R. Hauser,* C. W. Olanow, ‡ cocaine exposure. Cocaine also downregulated cyclin A2 in human and J. Kordower † neural progenitor cells, A2B5+ progenitors, and in fetal rat brains exposed to cocaine in utero. Compensating for cyclin A downregulation *Department of Neurology and Neurosurgery, University of South by cyclin A2 plasmid transfection reversed the inhibition of cell prolif-Florida, Tampa, FL, USA eration by cocaine. Transcriptional regulators of cyclin A2 were †Department of Neurological Sciences and Center for Brain Repair, screened, resulting in identification of ATF4 as being the mediator of Rush University Medical Center, Chicago, IL, USA cocaine-induced cyclin A2 repression. ATF4 is an indicator of endo- ‡Department of Neurology, Mt. Sinai School of Medicine, New plasmic reticulum (ER) stress. We determined that cocaine causes ac-York, NY, USA cumulation of reactive oxygen species (ROS) in AF5 cells due to Noxidation of cocaine via cytochrome P450. Cocaine-induced ROS accumulation causes ER stress as evidenced by increased phosphoryla-
We have previously reported that Parkinson's disease (PD) does not influence the short-term (18-month) viability of fetal nigral trans-tion of EIF2α and increased expression of ATF4. Finally, in developing fetal rat brains, cocaine inhibited neural precursor proliferation in plants in patients with PD. However, new long-term (4-and 14-year) postmortem cases in PD patients that receive transplants demonstrate the ventricular proliferative zone while increasing cyclin A2 expression. Therefore, downregulation of cyclin A2 mediates the inhibition that markers of PD (alpha-synuclein and ubiquitin) are expressed 466 ABSTRACTS within the grafts. These results indicate that 1) PD can attack grafted Antinociceptive Effect of the Peptides Conantokin-G and Conotoxin MVIIA in Rat Models of Chronic Pain cells in a manner similar to what is seen in the parkinsonian substantia nigra, 2) the disease can be expressed within neurons that are genetically unrelated to the patient with PD, and 3) the disease is S. Gajavelli, A. Hama, and J. Sagen expressed in grafts that are unrelated immunologically to the patient with PD.
Miami Project, University of Miami, Miami, FL, USA Peptides derived from Conus marine snails Conantokin-G (con-G) and conotoxin MVIIA have been previously demonstrated to antago-MASH1 Forced Expression and FGF-2 Deprivation Exert nize the N-methyl-D-aspartate (NMDA) receptor and N-type calcium Complementary Neuronal Enrichment Effects in Cultured channels, respectively. These peptides have the potential to be recom-Rat Embryonic Neural Precursor Cells binantly expressed in cells and placed in the intrathecal (IT) space for long-term pain relief. As a prelude to recombinant peptide generation, their effects alone and in combination in rat models of chronic pain O. Furmanski,* † S. Gajavelli,* J. Huang,* and J. Sagen* † were evaluated. Following IT injection of either con-G, MVIIA, or vehicle, 5% formalin was injected into the plantar left hind paw and *The Miami Project to Cure Paralysis, University of Miami Miller the number of flinches within 1 min was counted at 5-min intervals School of Medicine, Miami, FL, USA for a total of 60 min. In a separate group of rats, the left spinal nerve †Neuroscience Program, University of Miami Miller School of roots L5 and L6 were tightly ligated, leading to a significant decrease Medicine, Miami, FL, USA in withdrawal threshold of the left hind paw. The effect of IT injection of either peptide alone, in 1:1 combination, or vehicle on tactile hypersensitivity was measured for up to 2 h. In rats IT injected with vehicle, Several CNS disorders exhibit dysregulation of inhibitory neuroa biphasic pattern of formalin-evoked flinching was observed. In contransmission as a component of their sequelae. This loss of inhibition trast, IT injections of either con-G or MVIIA alone led to a dosesignaling is often treated with drugs that act directly or indirectly to dependent decrease of hind paw flinching. In rats with a spinal nerve promote γ-aminobutyric acid (GABA) signaling. Transplantation of ligation, IT injection of either peptide dose-dependently increased GABAergic cells is a possible alternative strategy for targeting treatwithdrawal thresholds. However, the highest antinociceptive dose of ment specifically to the site of disinhibition in the damaged or diseased MVIIA tested led to visible tremor-like effects. In contrast, 50% effecnervous system. We have focused on enriching neurospheres (NS) for tive dose of MVIIA, when combined with con-G, produced potent GABAergic neurons, while attenuating gliogenesis, for use in transantinociception without evidence of such adverse side effects. The data plantation as neuropathic pain therapy in vivo. Neurogenesis may be suggest that con-G or MVIIA ameliorates long-term pain caused by promoted via either extrinsic signaling or intrinsic molecular mechaperipheral tissue injury by decreasing activity at spinal dorsal horn nisms. Because previous results in our laboratory and others suggest NMDA and N-type calcium channels, respectively. The side effect that decreasing FGF-2 signaling (extrinsic) or increasing MASH1 tranobserved with a therapeutic dose of MVIIA was not observed when scription factor expression (intrinsic) independently can modestly procombined with con-G. Thus, this combination may be ideal for develmote GABAergic neurogenesis in vitro, we examined whether combinopment of gene therapy or cell-based delivery systems. ing these conditions would further improve GABAergic neurogenesis. To quantify GABAergic neural precursor cells (NPCs) and proliferation in vitro, naive and MASH1-transduced (MASH1-x) NS were plated at passages 0 through 3 in one of three different media for 2 Transplantation of Cord Blood Monocyte/Macrophage Cells days: 10 ng/ml FGF-2 (normal), 1 ng/ml FGF-2 (low), and 10% FBS.
to Treat Sanfilippo Type B Proteins were harvested at passages 0 through 3 from NS suspension cultures to assess overall levels of phenotypic marker expression. Im-S. Garbuzova-Davis,* † ‡ § Y. Xie,* P. Danias,* C. D. Sanberg,** munocytochemistry revealed that percentages of GABA-immunoreac-S. K. Klasko,# and P. R. Sanberg* † ‡ § ¶ tive (-ir) NPCs decrease through successive passages in all NS cultures, but low FGF-2 NS contains the highest proportion of GABA-IR *Center of Excellence for Aging and Brain Repair, University NPCs and appears to sustain a small subpopulation at all time points.
of South Florida, Tampa, FL, USA MASH1 forced expression did not have substantial effects on GABA- †Department of Neurosurgery, University of South Florida, Tampa, IR NPC proportions. BrdU incorporation was highest in normal FGF-FL, USA 2 NS, and MASH1-x NS contained higher proportions of BrdU-IR NPCs at later passages compared to naive NS. Nestin and β-III-tubulin ‡Department of Molecular Pharmacology and Physiology, University staining suggest MASH1-x NS were more prolific and produced more of South Florida, Tampa, FL, USA immature neurons than naive. Western blotting demonstrated that the §Department of Pathology and Cell Biology, University of South lenti-MASH1 vector forced substantially increased MASH1 protein Florida, Tampa, FL, USA expression. MASH1-x NS showed increased β-III-tubulin expression ¶Department of Psychiatry, University of South Florida, Tampa, compared to naive, although expression decreased through successive FL, USA passages. MASH1-x NS showed considerably decreased CNPase ex-#College of Medicine, University of South Florida, Tampa, FL, USA pression compared to naive, whereas GFAP was unaffected. Depriving **Saneron CCEL Therapeutics, Inc., Tampa, FL, USA NS of FGF-2 for 3 days prior to protein harvest increased β-III-tubulin and decreased CNPase and GFAP expression. Furthermore, FGF-2 deprivation and MASH1 forced expression together showed additive
In Sanfilippo syndrome type B (MPS III B), a deficiency of alpha-N-acetylglucosaminidase (Naglu) enzyme leads to accumulation of he-reduction of CNPase expression. These data together suggest that FGF deprivation and MASH1 may act in tandem to promote neuronal paran sulfate (HS), a glycosaminoglycan (GAG), within cells and to eventual progressive cerebral and systemic organ abnormalities. We marker expression while decreasing glial marker expression. Attenuating gliogenesis is an important technical improvement in the overall have previously shown that mononuclear cells from human umbilical cord blood (MNC hUCB) cells that contain and release the Naglu en-goal of enriching NPCs for neuronal cells in vitro. However, exposure to media manipulation longer than 2 days may be required to promote zyme, ameliorated/prevented pathological changes after injection into the cerebral lateral ventricle of 1-month-old Naglu-deficient mutant GABAergic differentiation. Mimicking the complex interplay of gene expression and environment during neural development in vivo will mice. Benefits were also determined from intravenous (IV) MNC hUCB cell administration into early (3-month-old) or late (6-month-likely play an important role in effecting neuronal differentiation from long-term NPC cultures. old) symptomatic mice. Additionally, we demonstrated that IV administered volume-reduced nucleated hUCB cells also benefit mice Supported by NS51667.
modeling MPS III B. However, for additional hUCB cell benefits, present on microglia cells, suggesting that fractalkine regulates signaling between neurons and microglia. Recently, it has been shown that mechanisms of phagocytic clearance in this HS-rich environment need to be investigated. Removing accumulated HS is critical to our trans-CX3CR1 is critical for regulating the function of microglia and that its ablation induces excessive microglia activation in response to in-plant strategy. GAGs, such as HS, are extracellular matrix macromolecules that affect the phagocytic properties of macrophages. Also, the flammatory stimuli. It was the goal of this study to determine if an impaired CX3CR1/fractalkine function may modulate the decrease in known ability of dead cells to bind to HS on the surfaces of macrophages may assist in phagocytic clearance. However, the function of hippocampal cell proliferation associated with aging. We analyzed cells positive for 5′-bromodeoxyuridine (BrdU, 50 mg/kg) in animals monocytes/macrophages in a HS-rich environment such as Sanfilippo syndrome is unclear. The aim of our study was to determine the effect in which the action of CX3CR1 was inhibited. Aged (22 months) and young (4 months) rats received anti-rat CX3CR1 (10 µg/10 µl) or of IV transplantation of monocyte/macrophage cells from hUCB (m/m hUCB) into a mouse model of MPS III B. The m/m hUCB cells rabbit IgG for 7 days intracerebroventricularly through a brain infusion cannula connected to an osmotic minipump. On day 6 all animals re-(3 × 10 6 ) or media were injected into male and female Naglu mice at 3 months of age. Our behavioral results demonstrate that IV adminis-ceived two injections of BrdU at 12-h intervals. Animals were perfused the following day. Unbiased stereology analyses revealed that tration of m/m hUCB cells into Naglu mice has a partial beneficial effect biased by sex. Behavioral improvements (decreased hyper/ste-the blockade of CX3CR1 function in young rats significantly decreased the number of proliferative cells in the subgranule zone of the reotypical activity and improved cognitive function) indicated advantages of m/m hUCB cells. However, gains in amelioration of locomo-dentate gyrus when compared to control. Interestingly, the blockade of CX3CR1 did not affect cell proliferation in the aged animals. These tor dysfunction (declining hyperactivity) were mostly seen at 3 months posttransplant in females. Sex-based differences were also noted in findings indicate that the fractalkine receptor CX3CR1 is essential for regulating adult hippocampal cell proliferation. It is possible that the performance of learning/memory tasks. Although m/m hUCB-treated mutant males and females showed improved learning during the post-lack of effect observed in the aged hippocampus may be due to a preexisting, impaired function of CX3CR1 and further inhibition of transplant period, improved memory was only observed in m/m hUCB −/− female mice at 1 month after transplantation. Three months post-this receptor might not exert additional effects. This work was supported by the National Institutes of Health transplant, analysis of microglia in the brain of Naglu mice demonstrated that microglia numbers increased in all hippocampal areas of (AG024165A, AG04418) and the VA Medical Research Service. treated mutant mice of both sexes. Although activated microglia were slightly reduced in the CA2 and dentate gyrus regions in these treated
Motor Function and Memory Loss With Aging: mice, microglia activation in the CA3 region seemed to be increased Are They Related? in m/m hUCB −/− transplanted mice when compared to media −/− mice. The m/m hUCB cells were found widely distributed within and
A.-C. Granholm,* H. Boger,* and L. M. Middaugh † outside the CNS. In the liver, the majority of cells expressed CD68. Quantitative HS measurements in the livers showed a tendency towards reduced levels in treated mutant mice. In addition, urine bladder *Department of Neuroscience, and the Center on Aging, Medical distention, usually a major problem in older Naglu mutant mice, was University of South Carolina, Charleston, SC, USA ameliorated in both treated males and females. Results suggest that †Psychiatry, and the Center on Aging, Medical University of South administration of m/m hUCB cells should benefit mice modeling San-Carolina, Charleston, SC, USA filippo syndrome III B, probably due to the involvement of transplanted cells in mechanisms of phagocytic clearance in the HS-rich
The association of the neurodegenerative diseases, Alzheimer's environment of MPS III B. However, using m/m hUCB cell fraction disease (AD) and Parkinson's disease (PD), as well as depression with in cell-based therapy for MPS III B might not be the best approach. It aging suggests the possibility that they might at least partially be mediis likely that more benefit could be obtained with a combination of ated by similar brain degenerative processes. Interestingly, the incim/m hUCB and MNC hUCB cell fractions.
dence of AD and PD increases at the same rate during the aging pro-Supported by: Lauren's Hope Foundation and Saneron CCEL cess, the combination finally afflicting near 40-50% of the population. Therapeutics, Inc. S.G.-D. is a consultant and P.R.S. is a cofounder These conditions have other commonalities such as similar risk facof Saneron CCEL Therapeutics, Inc.
tors, pathological findings, and gender distribution. The biological mechanisms for the mirrored incidence and progression for AD and PD could potentially be as simple as reduced transmitter function with Fractalkine Receptor CX3CR1 Regulates Adult Hippocampal age, albeit in different brain regions. For example, both serotonin (5-Cell Proliferation HT) and norepinephrine (NE) are involved in mood, movement, and memory, and both transmitters decline with aging as well as in AD and PD. Interestingly, it has been suggested that brain stem NE neurons C. Gemma,* † A. Schlunk, ‡ M. J. Cole,* C. E. Hudson, † degenerate prior to the cholinergic (ACh) neurons in AD and prior A. D. Bachstetter,* M. Fister,* M. Wingert, § P. R. Sanberg,* to substantia nigra dopamine (DA) neurons in PD. Other biological and P. C. Bickford* † mechanisms common to AD and PD include: oxidative stress, inflammation, generalized neuronal degeneration, and altered growth factor *Center of Excellence for Aging and Brain Repair, Department support. This review will focus on common grounds for AD and PD of Neurosurgery, University of South Florida, Tampa, FL, USA as well as "normal" aging processes to elucidate possible development †James A. Haley VA Hospital, Tampa, FL, USA of more appropriate animal models for these interrelated processes. ‡Honors College, University of South Florida, Tampa, FL, USA This work was supported by a Program Project Grant from the §College of Arts and Sciences, University of South Florida, Tampa, National Institutes on Aging (AG023630). FL, USA poorly understood. We previously showed that the receptors for certain recovery assays (phenol red solution, 1.5 ml/rat; PO) on GI emptying/ transiting at 48 h or 4 weeks postinjury (PI). Compared with controls, class 3 semaphorins (Sema 3A and 3F) are expressed in the adult nigrostriatal pathway. Here we demonstrate that Sema 3A and 3F recep-SCI significantly increased dye recovery rate (DRR, determined by spectrophotometry) in the duodenum (+84.6%) and stomach (+32.6%), tors (neuropilin 1 and 2, plexin A1 and A3, L1-CAM and NrCAM, respectively) are expressed during formation of the mtDA pathways but decreased it in the jejunum (−64.1% and −49.5%) and ileum (−73.6% and −70.1%) at 48 h and 4 weeks PI, respectively (p ≤ 0.005, and bind the ligands that, moreover, have functional effects on ventral mesencephalic (VM) DA axons in vitro. Sema 3F, but not Sema 3A,
ANOVA with post hoc t-test). Electrophysiological analysis revealed that purinergic fast inhibitory junction potential (IJP) was reduced strongly induces collapse of embryonic VM DA growth cones. Cocultures of E14 VM explants and constitutive ligand-expressing 293T cell ϳ30% in the antrum and duodenum of rats 48 h PI (A/n = 3/7; p < 0.001), and slow IJP was essentially abolished. Immunocytochemistry aggregates were performed. Sema 3A can both repel and attract, whereas Sema 3F strongly repels, DA axons. The repulsive effect of consequently uncovered significant reductions in the GI VIP and nNOS (i.e., slow IJP mediators) reactivity at 48 h and 4 weeks PI, Sema 3F is absent in neuropilin 2 (the Sema3F ligand binding subunit) knockout mice. The results point to an active involvement of Sema suggesting that SCI disrupted interstitial neurotransmission. Importantly, SCI caused discernible atrophy of the GI mucosa and muscle 3A, and especially Sema 3F, in the initial steering of the VM DA towards the telencephalon. Understanding the molecular cues that coat (e.g., the two layers of gastric wall were correspondingly 28% and 27% thinner 4 weeks PI). We conclude that contusive SCI triggers guide DA axons to their targets may yield clues to better understand and treat the degeneration of the nigrostriatal pathway in Parkinson's GI abnormalities with unique pathophysiology and pathology in different segments. Such GI disorders evolve continuously during the entire disease.
Supported by NINDS K08 NS46322 to R.E.G. post-SCI period examined, and may require therapeutic development to target specific underlying mechanisms. assessed by open field motor activity and accelerating rotarod meatowards 80%. The scientific work towards regenerating or replacing surement procedures. Although these measurements have been very dysfunctional organs, tissues, and cells involves most fields of biology helpful as an initial behavioral assessment tool, more quantitative and and medicine. There are many examples of groundbreaking scientific detailed description of the motor behavior of the mice might provide discoveries providing potential future advances for patients. This preadditional incite in the aging and disease processes. It was the purpose sentation addresses current and future opportunities to reach novel disof this study, therefore, to develop a three-dimensional kinematic coveries and attempts to highlight many fields of cell regeneration and mouse model and data collection procedure to provide a more thorrepair that have unique scientific and medical futures. ough analysis of movement alterations induced by disease or the aging process and their treatment. GDNF +/− mice and wild-type littermates were anesthetized with isoflurane and six retroreflective markers were This preliminary study demonstrated that locomotion velocity was Gastrointestinal (GI) abnormalities resulting from spinal cord injury (SCI) are challenging disorders that have not been examined ex-greatly reduced for the aged GDNF +/− mouse with a peak velocity approximately half that of the young wild-type mouse. The study demon-perimentally using clinically relevant models. In this study, female Sprague-Dawley rats (n = 5/group × 4: T10-T11 contusion, laminec-strates, for the first time, that three-dimensional movement can be captured and measured in animal models of disease and could provide a tomy, or naive) were fasted for 24 h before being submitted to dye more refined technique for assessing movement dysfunction associated delivery of neurturin using an AAV vector delivery system would be safe and effective for patients with Parkinson's disease. As part of a with neurodegenerative diseases and the aging process.
Repair and Regenerative Medicine
This work was supported by a pilot grant from the MUSC Center larger series of studies, experiments performed in nonhuman primates demonstrated that AAV-NTN: 1) continues to be expressed for up to 1 on Aging (T.K.) and a Program Project Grant from the National Institutes on Aging (AG023630).
year in normal monkeys, 2) augments the expression of dopaminergic markers as well as the trophic factor marker phospho-erk for up to 1 year in normal monkeys, 3) augments the expression of dopaminergic Graft Overgrowth and Ependymal Cyst Formation Despite markers as well as the trophic factor marker phospho-erk in aged mon-Initial Clinical Improvement in a Huntington's Patient Who keys, 4) prevents motor deficits, preserves striatal dopamine, preserves Neural cells with astrocytic characteristics have the potential of System, Seattle, WA, USA stem/progenitor cells, in vitro. Here we report that immature fetal **Children's Hospital and Regional Medical Center, Seattle, astrocytes designated as normal human astrocytes (NHA), express WA, USA GFAP, vimentin, nestin, and low levels of beta III tubulin, an early † †Neurosciences Institute, St. John's Regional Medical Center, neuronal marker, as well as mesenchymal associated markers, fibro-Oxnard, CA, USA nectin and collagen-1. When primary NHA cells were cultured in conditions supporting the growth of neural cells (serum-free DMEM/F12 Previously our group reported the first two autopsies of longmedia supplemented with bFGF) these cells differentiated into both surviving patients with human fetal neural transplants for Huntington's neurons and astrocytes. This dual progeny was generated after withdisease (HD). Herein we describe a third patient with HD who redrawal of bFGF from the culture media. Changing of tissue culture ceived multiple bilateral intrastriatal transplants of human fetal lateral condition to alpha-MEM media containing 10% FBS resulted in transiganglionic eminence, one of which was accompanied by a short segtion of primary NHA cells into fibroblast-like cells. The fibroblastment of autologous sural nerve. The patient was followed using stanlike cells were identified based on their morphological features. They dard UHDRS assessments for 2 years, during which time many of the expressed vimentin, fibronectin, and collagen-1, and we noted a deassessments stabilized or improved, including timed tasks, UHDRS cline in the expression of neural markers. When cultured in osteogenic motor and behavioral indices, and total functional capacity. However, and adipogenic induction media, the fibroblast-like derivatives of after follow-up the patient's HD symptoms progressively worsened.
astrocytes differentiated into osteoblasts and adipocytes. Analysis of She gradually developed hemiparetic symptoms, prompting imaging gene expression demonstrated a quantitative change in marker expreswhich showed a 3-cm neostriatal cyst. The patient eventually died due sion pattern depending on the culture environment. This involved to complications of HD 108 months posttransplantation. Multiple upregulation of mesenchymal markers with concomitant downregulagrafts, up to 2.9 cm in greatest dimension, and several large ependymal tion of ectodermal markers. These findings suggest that proliferative cysts, up to 2.0 cm in greatest dimension, were identified and exhibited brain cells have the capacity to generate neurons, astrocytes, and mesclear mass effect on adjacent structures, including the posterior limb enchymal cells under the influence of environmental factors. This of the internal capsule. The masses were composed of mature but diswork has implications for induction of repair in the nervous system. into the striatum of nonimmunosuppressed parkinsonian animals and hRPEC allografts in Parkinson's disease patients have shown signifi-Center, Chicago, IL, USA cant amelioration of parkinsonism with no evidence of a host immune †Ceregene Inc., San Diego, CA, USA response or graft rejection. The mechanisms involved in the apparent immune tolerance of hRPEC after transplantation is not clear. One Ceregene Inc. has performed a robust series of preclinical safety and efficacy experiments testing the overarching hypothesis that gene potential mechanism is that hRPECs secrete factors such as pigment 470 ABSTRACTS epithelial derived growth factor (PEDF) that alter microglial activa-ence of interneurons associated with the PhMN circuit, suggesting the CPP may entail a more complex neural substrate than envisioned thus tion. To determine whether hRPECs secrete factors capable of suppressing microglial cytokine expression we analyzed the effects of far. The present study first examined the distribution of these interneurons and their integration with the phrenic circuit in the normal and hRPEC-conditioned media or media containing PEDF on mRNA expression levels of proinflammatory cytokines by murine microglial injured spinal cord (C2 Hmx). For this purpose, the diaphragm was surgically exposed in anesthetized animals and attenuated PRV was cells. We also investigated whether the activational state of the microglia was important in the response to the various media. Activation of administered to the left hemidiaphragm. Animals were then collected for histology at 48-72 h post-PRV delivery. Analysis of normal tissue the microglial cultures was achieved by overnight interferon-γ (IFN-γ; 10 ng/ml for 10 h) treatment followed by addition of lipopolysacharide demonstrated a bilaterally distributed population of interneurons premotor to the PhMNs. In addition, examination of specimens from C2 (LPS; 100 ng/ml) for another 8 h. Activated and unactivated microglia were extensively rinsed and incubated for 40 h with either uncondi-Hmx animals showed that the number of these cells and their connectivity with the PhMN pool remains stable. In a second set of animals, tioned media, hRPEC-conditioned media, or media containing PEDF (100 ng/ml). RNA was isolated from each group and mRNA expres-the rVRG was stereotaxically located, electrophysiologically identified, and Miniruby (VectorLabs) delivered by iontophoresis. Ten days sion of IL-1β, IL-6, and TNF-α was analyzed by RT-PCR using specific primers. Results of three independent experiments were com-following Miniruby injection, PRV was administered to the ipsilateral diaphragm and animals were subsequently perfused for histology 64 h bined and statistical analysis performed using Relative Expression Software Tool (REST). IFN-γ/LPS activation of microglia cells led to later. Miniruby-labeled terminals closely approximated a subset of these interneurons both ipsi-and contralateral to the infected PhMN significantly elevated expression of all three cytokines compared to unactivated microglia cells when incubated with unconditioned media pool. To date, bypass pathways have only been associated with locomotor recovery. Our present findings indicate that a similar substrate (p < 0.001), confirming that treatment leads to microglial activation. Expression of mRNA for IL-1β was increased 5.3-fold, TNF-α 2.5-may be available for respiratory recovery after SCI, although their functional properties remain to be defined. Nevertheless, their anatom-fold, and IL-6 3.9-fold as a result of IFN-γ/LPS activation. Incubation of activated microglia with hRPEC-conditioned media led to a signifi-ical integration with the PhMN circuit indicates they may play a role in regulating expression of the CPP. Future studies aim to characterize cant reduction in cytokine mRNA expression when compared to activated microglia incubated with unconditioned media. IL-1β expression changes in rVRG projections to the phrenic nuclear region, as well as possible alterations in respiratory-associated brainstem maps. was reduced 2.8-fold (p < 0.019), while IL-6 expression was decreased 2.0-fold (p < 0.001) and TNF-α expression was reduced 1.6-Supported by 1RO1NS054025 and the Craig H. Neilsen Foundation. fold (p < 0.001). Incubation of activated microglia cells with PEDFcontaining media did not result in significant reductions in IL-1β or IL-6 mRNA expression when compared to activated microglia incubated in unconditioned media but did lead to a significant 1.3-fold Monocyte Gene Therapy in Alzheimer's Disease APP؉PS1 reduction in TNF-α mRNA expression (p < 0.007). We observed no Transgenic Mice effects of hRPEC-conditioned media or PEDF-containing media on mRNA expression of the three cytokines when microglia cells were L. A. Lebson,* S. G. Kamath, † K. Nash, ‡ N. Muzyczka, ‡ not activated by IFN-γ/LPS treatment. These results demonstrate that D. Morgan,* and M. N. Gordon* hRPECs secrete soluble factors capable of reducing microglial activation as measured by proinflammatory cytokine mRNA expression, and this ability may provide a mechanism for explaining the immune toler-*Alzheimer's Research Laboratory, Department of Molecular ance of hRPEC in xenotransplanted brain. We also show that PEDF, Microglia and macrophages function to protect the nervous system by serving as debris scavengers and regulators of immune responses.
Could Interneurons Contribute to Respiratory Plasticity
Studies implicating the homing of monocytes to regions of CNS dam-Following Cervical Spinal Cord Injury in Rat?
age have led to the idea that these cells could be used to deliver therapeutic genes to the brain in Alzheimer's disease. Several Aβ-degrading M. A. Lane,* T. E. White,* D. D. Fuller, ‡ and P. J. Reier* proteases have been identified by their ability to cleave Aβ. Neprilysin (NEP), insulin degrading enzyme, and endothelin converting enzyme *Department of Neuroscience, University of Florida, Gainesville, have been reported to affect Aβ levels in the brains of experimental FL, USA animal models. Recent in vitro and in vivo studies demonstrate that †Department of Physical Therapy, University of Florida, Gainesville, the upregulation of Aβ-degrading enzymes can significantly reduce FL, USA the accumulation of the Aβ peptide. Identification of a method to selectively upregulate brain neprilysin activity may provide a new therapeutic potential. To study the effects of neprilysin-transfected mono-While the potential for plasticity following spinal cord injury (SCI) is becoming more widely appreciated, the underlying mechanisms and cytes on Aβ, we utilized bone marrow harvested aseptically from 8-10-month-old C57BL/6-Tg mice that express green fluorescent pro-synaptic relationships are still not well understood. However, recent studies have shown that novel recruitment of interneurons can contrib-tein (GFP) under the control of the human ubiqutin C promoter. Cells were mixed with microbeads conjugated to CD11b+ antibody in order ute to functional recovery. Whether this is limited to locomotion or applicable to other forms of recovery has not been explored. One ex-to separate monocytic population from entire bone marrow cells using a magnetic field. Nine-month-old APP+PS1 transgenic mice received ample of spinal plasticity is the crossed-phrenic phenomenon (CPP), which occurs following a lateral C2 hemisection (Hmx). In this model, 5 × 10 6 GFP+ CD11b+ monocytic cells injected into a microvascular port once a week for 2 months and the mice were sacrificed 1 day the hemidiaphragm is paralyzed due to interruption of descending ipsilateral fibers from the rostral ventral respiratory group (rVRG) to after the last injection. Group 1 received monocytes that were transfected with a neprilysin construct in which the membrane binding domain phrenic motoneurons (PhMNs). Some recovery of PhMN activity subsequently occurs. This has been attributed to activation of normally, was replaced with a signal peptide triggering secretion sequence, appended with HA tag (NEP-S-HA). This construct generates a secreted crossed latent monosynaptic projections from contralateral rVRG axons. However, transynaptic tracing studies using pseudorabies virus form of neprilysin in transfected cells. Group 2 served as the untreated control group and provided a baseline for immunohistochemical mea-(PRV, a retrograde transynaptic tracer) have demonstrated the pres-ABSTRACTS 471 surements. Fluorescent immunostaining for GFP and HA qualitatively †Department of Molecular Genetics and Microbiology, University demonstrated that the monocytes had been transfected with neprilysin of New Mexico, Albuquerque, NM, USA and had migrated to the brain in the vicinity of the plaques. Significant ‡Department of Molecular Medicine, University of South Florida, decreases in Aβ staining were measured in the frontal cortex and hip-Tampa, FL, USA pocampus between the treated mice and the control group by computer-assisted image analysis. There were also decreases in Congo red Previous work has shown that Qβ bacteriophage-based Aβ N-terstaining between the treated and control group. Therefore, manipulatminal aa1-9 short peptide vaccine induced high antibody titers against ing monocytes to express an amyloid-degrading enzyme such as nepri-Aβ in C57BL/6 or SJL mice. The antibodies were predominately lysin offers a powerful novel therapeutic tool for the treatment of Alz-IgG2c, characteristic of a Th1-type response. In this study we vacciheimer's disease.
nated APP transgenic mice (Tg2576) at age of 9 months with either Technical support provided by Margi Baldwin. Supported by AG Aβ 1-9 (10 µg) or C-terminal Aβ 28-40 (10 µg) conjugated to Qβ 15490.
bacteriophage without using adjuvant. Our data showed that mice immunized with the Aβ 1-9 peptide elicited high IgG antibody titers against Aβ 1-40 (average titer 4.37 mg/ml; n = 6) compared to the Aβ Selective Gene Expression Changes Following Polarization 28-40 peptide (average titer 0.91mg/ml; n = 6) after two inoculations.
Towards Classical or Alternative Activation of Microglial
However, following eight monthly boosts the anti-Aβ 40 IgG titers in the Mouse CNS induced by the Aβ 1-9 were gradually decreasing, whereas the Aβ 28-40 domain increased the titers following each boost and reached D. C. Lee, L. Lebson, D. Morgan, and M. N. Gordon maximal antibody levels at the fourth boost. Interestingly, immunization with Aβ 1-9 peptide induced strong IgG1 and IgG2b, Th2-type, Alzheimer's Research Laboratory and Department of Molecular immune response with lower IgG2a and IgG2c in all six immunized Pharmacology and Physiology, University of South Florida, Tampa, APP transgenic mice. Vaccination with Aβ 28-40 peptide predomi-FL, USA nantly elicited IgG2b immune response and IgG1 titers that were similar to IgG2a and IgG2c. Intriguingly, the Aβ 1-9 domain induced a The role of microglia/macrophages during neuroinflammation and robust anti-Aβ 1-40 IgM response. From the second immunization neurodegenerative diseases has been controversial due to various exthrough the final boost, IgM titers were much higher than the IgG pression markers, activation states, and stimuli. To date, at least two response induced by this immunogen. The Aβ 28-40 vaccine failed activations states have been suggested, consisting of a classical reto induce an IgM response. There was no anti-Aβ antibody response sponse (M1) comprised of tissue damage, inflammation, and pathogen in mice vaccinated with PBS vehicle control. Both vaccines reduced destruction, whereas the alternative response (M2) leads to tissue reamyloid burden in the brain in APP transgenic mice and the Aβ 28-40 pair and suppression of inflammation. Identifying biomarkers of mipeptide also significantly enhanced circulating total Aβ levels. Thus, croglia representative for the various activation states may help elucithis novel Aβ vaccination approach could be more effective with a date disease course and understand repair mechanisms. In these studies greater safety profile than traditional vaccines using adjuvants in Alzwe performed intraparenchymal injections into the hippocampus (HPC) heimer's disease therapy. with different cytokine cocktails designed to selectively elicit either an M1 or an M2 bias into middle aged (12 months old) mice. The M1 cocktail contained TNF-α, IL-12, and IL-1β, whereas the M2 cocktail Synaptic Reintegration of Grafted Dopamine Neurons in Mouse consisted of IL-13 and IL-4. Previous studies from our lab examined Model for Parkinson's Disease known microglial markers for selective activation in response to either classical or alternative activation following these cocktails. However, P. Licznerski, P. J. Hallett, and O. Isacson to identify novel and more selective markers, microarray analysis was performed on hippocampal tissue 3 days postinjection, comparing two Neuroregeneration Laboratories, McLean Hospital/Harvard Medical different gene array platforms. Furthermore, gene activation was com-School,Belmont, MA, USA pared between M1 vs M2 stimulator cocktails; putative selective M1 activation markers were induced by the M1 cocktail by at least twofold greater than by the M2 cocktail, while putative M2-responsive genes Cell transplantation offers great possibilities of treating neurologiwere induced by the M2 cocktail to at least twice the level induced by cal disorders like Parkinson's disease. Previous studies show that the M1 cocktail. Several top genes selectively expressed for the M1 grafts of fetal DA neuroblasts (VM) replace the lost endogenous dopacocktail included CXCL13, haptoglobin, MARCO, and calgranulin B, mine neurons by establishing a new functional DA innervation of the while a smaller subset of genes was selectively induced by the M2 host striatum, which compensates for some of the behavioral deficits cocktail and consisted of FIZZ1, Spred2, and EAR 11. Real-time PCR in 6-OHDA-lesioned animals (animal model for Parkinson's disease). will be used to verify the cytokine induction of selected genes. These
The behavioral effects in DA neuron-grafted animals were shown to data reveal several potential markers that represent selective classical be directly dependent on the ability of grafted cells to establish new versus alternative activation at the gene level. Future studies will deaxonal networks in denervated striatum, which in turn would suggest termine whether and how activation through these diverse pathways that grafted cells function primarily through their afferent connections results in differences in microglial functions.
(release of dopamine). Our study focuses on the importance of such pacity, the ability to differentiate into multiple lineages, and the potent and College of Medicine, Hershey, PA, USA tropism for malignant glioma cells in the both transfected and non- †Department of Neurology, Southern Illinois University, Springfield, transfected MSCs. Using enhanced green fluorescent protein (eGFP) IL, USA as a reporter gene, we were able to transfect human umbilical cord ‡Hindu University of America, Orlando, FL, USA blood-derived mesenchymal strem cells (hUCB-MSCs) with higher efficiencies (80-81%) than conventional methods. In addition, there The dopamine-and cAMP-regulated phosphoprotein of 32 kDa were no changes of morphology and proliferative activity in the both (DARPP-32) is found in striatal medium spiny neurons and responds transfected and nontransfected cells. These cells also exhibited a simito dopamine and adenosine neurotransmission. Phosphorylation of the lar expression for the MSCs-related antigens CD90, CD29, and CD44. Thr75 or Thr34 site of this protein can lead to differential effects in They efficiently differentiated and characterized along the mesodermal the activation or inhibition of signaling enzymes and other target protissue as well as ectodermal tissue neurons. The migration ability to teins. The present study examined the role that DARPP-32 plays in cancer cells was also similarly in both cells. Thus, we concluded that hemiparkinsonian rodents exposed to antiparkinsonian medications.
microporation is superior to currently available methods to efficiently Rats were measured for baseline rotations by apomorphine injections transfect into MSCs without change of multiple stem cell properties (0.2 mg/kg) to identify any rotational preference prior to lesioning. and it would be a valuable method for development of MSC-based After unilateral 6-OHDA injections, rats were tested again for apomorgene therapy in clinical trials. phine-induced rotations. Only animals that had greater than seven rotations per minute were used (n = 10). This criterion validated the hemiparkinsonian state. Rodents were separated into three groups and CD34 + Stem Cell Therapy in Chronic Stroke Patientsexposed to levodopa (LD) at various doses (2, 4, and 6 mg/kg) with Phase I Trial benserazide (15 mg/kg) for 10 days. After 7 days of drug washout, animals received Mucuna pruriens (MP), an Indian herb known to have antiparkinsonian effects, coupled with benserazide for another 10 S.-Z. Lin,* W.-C. Shyu,* and H. Li † days. Amounts of MP were derived from the above doses because MP contains natural LD. The stepping and cylinder behavioral tests were *Center for Neuropsychiatry, China Medical University Hospital, used to identify preference of spontaneous forelimb usage in the hemi-Taichung, Taiwan parkinsonian animals before and after treatment. Drug-induced dyski- †Institute of Molecular Biology, Academia Sinica, Taipei, Taiwan nesias of forelimb, trunk, and neck were rated for severity. While dyskinesias were identified in only the forelimb contralateral to lesion, dyskinesias in the trunk and neck region caused medial impairment of Granulocyte colony stimulating factor (GCSF) has been used to movement. After approximately 30 days, a representative group of the activate and mobilize CD34 + stem cells from bone morrow to periphtreated hemiparkinsonian animals (n = 5) was euthanized. Brain tissue eral circulation. We demonstrated that GCSF could enhance the availwas stained with an anti-DARPP-32 antibody (Epitomics, 1710-1).
ability of circulating stem cells in acute infarct brain and improved the Histological results showed that a normal cohort of animals (n = 5) capacity in neurogenesis and angiogenesis in rats as well as acute had consistent DARPP-32 staining throughout the striatum. On the stroke patients. We further explored the possibility of using stem cell other hand, hemiparkinsonian animals exposed to antiparkinsonian therapy for treating chronic stroke patients. In chronic stroke rats, medications showed depleted levels of staining for DARPP-32. Dorsal CD34 + stem cells were labeled with iron nanobeads and sorted out by regions of the striatum showed less expression of DARPP-32 than ven-Clinimax. These CD34 + stem cells were then injected directly into the tral areas. These data suggest that there are long-term effects of infarct brain. The results showed that the treated rats had remarkable DARPP-32 expression in dyskinetic animals and such effects are not motor and behavior recovery. The implanted stem cells also secreted altered by exposure to MP. Previous studies suggest that phosphoryvarious trophic and homing factors and differentiated into neurons, lated Thr34 DARPP-32 in the striatum is increased in dyskinetic aniglia, and microvessels in the stroke brain. Based on these preclinical mals while phosphorylated Thr75 DARPP-32 is decreased. While the results, a phase I clinical trial using autologous CD34 + stem cell therpresent study used an antibody nonspecific for the phosphorylated apy for chronic stroke patients proceeded. Six patients (MCA infracstates of DARPP-32, future studies will examine its role in various tion for 6-60 months, NIH stroke score 9-20) were enrolled for autolrodent models of Parkinson's disease and how acute exposure of antiogous CD34 + stem cell therapy under IRB approval guidelines. GCSF parkinsonian drugs influence the mechanistic actions of DARPP-32 (15 mg/kg) was injected subcutaneously for 5 consecutive days. CD34 + phosphorylation. stem cells (5-8 million in 1 ml) were harvested and implanted along Funded in part by NCCAM R21 AT001607 and The Brain Repair the damaged pyramidal tract. Neurological functions were assessed by Research Fund at The Pennsylvania State University.
scores of NIHSS, ESS, EMS, and Barthel index (BI). MRIs were used to monitor changes of pyramidal tracts, blood flow, neural regeneration, and the movement of implanted stem cells in patients' brain. Brain metabolism was also monitored regularly by FDG PET scan.
Efficient Transfection of Human Umbilical Cord Blood-Derived
Motor evoke potential was used to detect the directly electrophysiolog-
Mesenchymal Stem Cells and Multiple Stem Cell Traits
ical connectivity between the motor cortex and hand. group was as greater as 70%, while the elder group was 30%, by 6 months follow-up. The motor evoke potential of the young patient group showed significant recovery, and their walking speed even dou-Human mesenchymal stem cells (hMSCs) are an attractive source of adult stem cells for therapeutic application. So efficient transfection bled after the transplantation. Brain metabolism also disclosed much improvement in the peri-infarction region 6 months after the transplan-of MSCs is needed for tissue engineering and for therapeutic use in cell and gene therapy. In this study, we demonstrated the use of micro-tation. Implantation therapy with CD34 + stem cells in chronic stroke patients is safe and feasible. Patients with age under 60 years old may poration's novel electroporation technology as a method to introduce plasmid DNA into mesenchymal stem cells (MSCs) with significantly have much faster and better improvement in their motor functions than the elder patients. greater efficiency than calcium phosphate, liposome-based reagent,
Copatterning of Neuroectoderm and Vascular Endothelium
rebral hOEC/ONF implantation showed much more improvement in neurological deficit following stroke than control rats.
[ 18 F]fluoro-2-at the Earliest Stages of Embryogenesis as Modeled by Human Embryonic Stem Cells (hESCs)
deoxyglucose positron emission tomography (FDG-PET) showed increased glucose metabolic activity in the hOEC/ONF-treated group. Transplanted hOECs/ONFs and endogenous homing stem cells coloca-J. Lindquist, D. Cheresh, and E. Y. Snyder lized with specific neural and vascular markers (stem cell fusion), and both enhanced neuroplasticity in the ischemic brain. Upregulation of Burnham Institute for Medical Research & University of California, SDF-1α and CXC chemokine receptor 4 (CXCR4) in hOECs/ONFs San Diego, La Jolla, CA, USA promoted neurite outgrowth of cocultured primary cortical neurons under oxygen glucose deprivation (OGD) conditions and in stroke ani-Throughout the adult vertebrate, the vascular network aligns mals through upregulation of cellular prion protein (PrP C ) expression. closely with the neural network, suggesting that development of these Therefore, the upregulation of SDF-1α and enhancement of CXCR4 systems may be coregulated. We have been attempting to model the and PrP C interaction affected by hOEC/ONF implantation mediated earliest stages of embryogenesis by employing hESCs to observe vasneuroplastic signals in response to hypoxic and ischemic microenvicular development in the context of the emergence of the three embryronments. onic germ layers. We observe two distinct neuronal subpopulations spontaneously arising, one that emerges in synchrony with the vascular network and another that originates outside of the early endothelium.
Cell Type-Specific Loss of p53 Function in Midbrain Our studies suggest that the first neuronal network represents the (neu-Dopaminergic Neurons Is Neuroprotective Against ral crest-derived) autonomic nervous system that closely associates 6-OHDA Toxicity with and invests the developing vasculature. The second neuronal population represents early central nervous system (CNS) (i.e., neural Y. Luo, C.-C. Kuo, C. Backman, and B. Hoffer tube)-derived neurons that are not dependent upon the vasculature but then come to copattern with it. We demonstrate codependence between National Institute on Drug Abuse, Intramural Research Program, blood vessel and autonomic neural patterning, because disruption of Baltimore, MD, USA neovascularization with a function-blocking antibody to integrin α&νβ3 or pharmacological inhibition of VEGFR2 selectively disrupts Parkinson's disease (PD) is a common neurodegenerative disease the vascular-associated neural networks, while the CNS neuronal popthat is characterized pathologically by specific cell loss of dopaminerulation is unaffected. These findings suggest that the constitutive mugic neurons in substantia nigra (SN). Patients with PD show increased tually coordinated copatterning of vascular endothelium and neural p53 immunoreactivity in morphologically damaged neurons. It has lineages are an intrinsic embryological program that is pivotal for enbeen shown that loss or compromised p53 function is protective in suring the emergence and appropriately patterned autonomically innerdopaminergic neurons in toxicant exposure models such as MPTP and vated vasculature as well as appropriately innervated and perfused ormethamphetamine. However, most of these studies are carried out usgans. It is still unclear which lineage is primarily responsible for the ing a traditional knockout technique in which both p53 alleles were patterning and what signal transduction pathways, gene expression disrupted in all the cells from the embryonic stem cell stage. Cancer patterns, and epigenetic changes are mediating this cross-talk. In short, development and a high frequency of abnormalities in neuronal tube our hypothesis is that cross-talk between vascular endothelium and development in traditional p53 ko animals can introduce confounding neural lineages (first autonomic and then central) results in copatternfactors into the interpretation of the results. Thus, a dopaminergic neuing during development to form adequately innervated vasculature ron-specific disruption of p53 function is needed to clearly answer the (i.e., vessels responsive to autonomic cues mediating dilatation and question whether p53 is involved in the death of DA neurons in PD constriction) as well as organs that are also well perfused and appromodels. To address these questions, we crossed the LoxP floxed p53 priately innervated. Future studies will address the following quesmouse line with a DAT-IRES-Cre mouse line in which the endogenous tions: (1) Determine whether neural and vascular lineages emerge DAT locus is replaced by a DAT-IRES-Cre expression cassette. This spontaneously within hESC cultures and in what temporal sequence.
gives us selective expression of cre and the subsequent excision of Are these populations homogeneous? (2) Determine whether neural p53 specifically in midbrain dopaminergic neurons (DAN) only. Efand vascular lineages interact and whether one lineage is pivotal for fectiveness of p53 disruption was confirmed by PCR, showing a spethe patterning of the other. (3) Determine receptor-ligand pairs, downcific deletion of p53 gene in SN but not in the cortex and other brain stream signal transduction pathways, and chromatin modifications trigregions in DAT-IRES-cre/LoxP p53 mice. Loss of the p53 gene in gered by this cross-talk. DAN to the sham groups. In these animals we also found that numerous BrdU-labeled cells were present in the striatum proximal to the trans-of Medicine, Tampa, FL, USA plant site. A comparison of animals administered BrdU before, and those after, transplantation indicated that many of these cells were Amyotrophic lateral sclerosis (ALS) is a neurodegenerative disorlikely to be migrating endogenous precursors. In addition, in grafted der characterized by a loss of upper and lower motor neurons in the animals, doublecortin-positive (Dcx+) neuronal progenitors (which motor cortex, brainstem, and spinal cord. Development of an effective were hPAP negative) were observed close to the graft, suggesting that treatment is complicated by our poor understanding of the underlying NPC transplantation had induced neurogenesis and recruited endogecause(s) of this disease and by the diffuse nature of motor neuron nous NPCs to the transplant site. Along with the above-mentioned death. One possible mechanism involved in ALS pathogenesis is endogenous NPC reaction to grafting, we observed a significant presblood-brain barrier (BBB) and blood-spinal cord barrier (BSCB) imervation of striatal tyrosine hydroxylase (TH) expression and SN TH pairment, further aggravating motor neuron damage. Recently, we cell number in 6-OHDA-lesioned animals that had received prior NPC showed (Garbuzova-Davis et al., 2007) disruption of the BBB and grafts as compared to the ones that did not. Our data indicate that NPC BSCB in areas of motor neuron degeneration in the brain and spinal implantation stimulates endogenous NPC proliferation, migration, and cord in G93A mice at both early and late stages of disease. Capillary neuronal differentiation (Dcx-positive staining) and that these events ultrastructure revealed endothelial cell degeneration, which, along with are associated with nigrostriatal protection. Ongoing studies are anaastrocyte degeneration, compromised the BBB and BSCB, resulting in lyzing (a) specific populations of endogenous NPCs and their interacvascular leakage. Human umbilical cord blood (hUCB) has been tions with the grafted NPCs, (b) some molecules through which the shown to contain a great amount of endothelial cell (EC) precursors.
two NPC populations may interact, and (c) the relation between the Cell therapy is one promising treatment approach for ALS: replacing NPC interactions and the extent of neuroprotection, at various times damaged EC to restore BBB function. The aim of this study was to after transplantation and 6-OHDA application. evaluate development of endothelial cells derived from mononuclear Supported by NS055295 and the Millennium Scholars Fund at hUCB (MNC hUCB) cells in vitro. The MNC hUCB cells (Saneron University of Cincinnati. CCEL Therapeutics, Inc., Tampa, FL) were plated into poly-L-lysinecoated 24-well plates at a density of 100,000 cells/cm 2 in Endothelial Cell Basal Medium (phenol red-free) with Endothelial Cell Growth Supplement for 5 weeks. The medium was changed weekly and cell Human Retinal Pigment Epithelial Cells (HRPECs) morphology was monitored using an inverted microscope. After 5
Are Critical to Protect Ocular Xenografts in the CNS weeks, cell cultures were fixed and immunocytochemistry for expres-Against Immune Rejection sion of CD146 (endothelial cell marker) was performed. Results show that morphology of MNC hUCB cells changed by 1 week after plating N. I. Marupudi, K. Venkiteswaran, A. M. Stull, and T. Subramanian from rounded to spindle shape. By 3-5 weeks in vitro, most cells developed endothelial-like cell morphology. Immunocytochemical Department of Neurology, Penn State University, Hershey Medical analysis showed that more than 80% of MNC hUCB cells expressed Center, Hershey, PA, USA CD146. Our results suggest that these endothelial cells derived from MNC hUCB may be useful in cell-based therapy for ALS by replacing Although the central nervous system (CNS) has historically been dysfunctional endothelial cells to restore the compromised BBB.
considered an immunologically privileged site, transplantation of cells/ tissue to the mammalian brain has resulted in immune responses with mechanisms differing from the body's general response. Other studies have shown that rejection can consistently be induced by certain provocative stimuli including the placement of a skin graft from the donor mouse to the host rat, Effective use of stem cells in transplantation relies on their ability to survive, integrate, and function in a biologically meaningful manner degeneration of the optic terminals in the vicinity of mesencephalicretinal grafts after contralateral host eye removal, and transient disrup-in vivo. In this context, recent reports indicate that the "niche" or local environment of the stem cell plays a critical role in determining its tion of the blood-brain barrier. Studies of mouse fetal ventral mesencephalic (FVM) xenotransplants into rats demonstrate significant increases fate. Even though endogenous neural precursor cells (NPCs) form an important component of the stem cell niche after transplantation, the in activated microglia, MHC class I/II antigen, macrophages, and other immunological markers. To maintain the FVM transplantation, long-cross-talk between exogenously transplanted and endogenous NPCs has not been studied and may have an important impact on the fate term immunosuppressive treatment was necessary. Immunosuppression was, however, not required in the HRPEC transplantation studies. and functions of the transplant as well as the endogenous stem cells and, ultimately, the potential for repair of the mature brain. Therefore, To date, HRPECs have been safely xenotransplanted into parkinsonian rats and monkeys and allotransplanted in patients with Parkinson's the aim of the present study was to investigate the interactions between exogenous (transplanted) and endogenous (resident) NPCs, in a 6-hy-disease (PD), providing significant behavioral improvement in the absence of host immunosuppression. HRPEC transplants do not show droxydopamine (6-OHDA) rat model of PD, in order to understand the contributions of these two cell types to each other's fates and on any evidence of cell proliferation or migration even at 3 months posttransplantation. Even without any immune suppression, stereotaxic in-the efficacy of transplantation-induced repair. Genetically labeled (hu- Marijuana is the most widely used illegal drug among women of new solution to the problem of long-term continuous immunosuppresreproductive age. Reports dealing with the effects of prenatal exposure sion that previous investigators considered as the sole solution for sucto this substance of abuse are still controversial. In particular, the imcessful CNS engraftment of ocular grafts. Although stressful injuries plications of possible long-term consequences of in utero exposure to can cause rejection of retinal tissue transplanted into the CNS, HRPEC cannabis derivatives on brain circuitry are poorly understood. In this cografts appear to confer immune stability to cografts via various putastudy the synthetic CB1 agonist WIN 55,212-2 (WIN) was administive mechanisms including apoptosis mediators (e.g., Fas/FasL), neutered daily to pregnant rats from gestational day 5 to 20 (0.5 mg/kg). rotrophic factors (e.g., pigment epithelium-derived factor), or other se-This dose is equivalent to a moderate or low exposure to marijuana in creted substances.
humans and has no overt toxic effects. The treatment with WIN did This project was funded in part by NINDS RO1 NS42402, HRSA not affect gestational and reproduction parameters and WIN-exposed DIBTH06321, PA Tobacco Settlement Research Fund, Brain Repair pups did not show any sign of malformations or malnutrition. Behav-Research Fund of Penn State University, Barsumian Trust, and Ameriiorally, however, prenatal treatment with WIN altered pup performance can Parkinson Disease Association.
in homing behavior and produced a decrease in the rate of separationinduced ultrasonic vocalizations. Behavioral deficits that resulted were long lasting, because prenatal WIN exposure caused a disruption of memory retention in young and adult offspring subjected either to a Redirecting Progenitor Cell Migration in the Normal Adult passive or an active avoidance task. Moreover, an analysis of dendritic Rodent Brain: A Role for Insulin-Like Growth Factor-1 (IGF-1) branching of Golgi-impregnated hippocampal granule cells of the dentate gyrus in prenatal WIN-exposed rats sacrificed at 40 and 80 days L. McGregor, M. Yang, and B. Connor old showed a significant increase in the amount of dendritic arbor and in the complexity of the dendritic trees at both ages compared to age-Department of Pharmacology, University of Auckland, Auckland, matched controls. These findings suggest that moderate exposure to New Zealand cannabinoids during crucial periods of brain development can cause dysmorphic maturation of the hippocampus associated with the failure of these neurons to undergo normal age-related dendritic pruning. The migration of subventricular zone (SVZ)-derived neural pro-Such subtle morphological alterations and commensurate changes in genitor cells along the rostral migratory stream (RMS) to the olfactory brain circuitry would be, in turn, a factor underlying the behavioral bulbs is tightly regulated by a number of local microenvironmental deficits observed both in early and late postnatal life. cues. Using in vivo gene transfer, we investigated whether IGF-1 could redirect the migration of neural progenitor cells from the RMS into the normal adult rat striatum. IGF-1 was overexpressed in adult Wistar rats by unilateral striatal injection of the viral vector, AAV 1/2 -Therapeutic Use of Human Cord Blood Cells IGF-1. Control animals received AAV 1/2 -Luciferase. Animals received in Parkinson Disease daily injections of the mitotic marker BrdU from 18 to 28 days after AAV 1/2 injection to label proliferating progenitor cells. Animals were M. B. Newman,* † A. P. Smith,* L. P. Kelly,* killed 4 or 8 weeks after AAV 1/2 injection. Migrating neural progenitor and R. A. E. Bakay* † cells were visualized by immunocytochemistry using the immature neuronal marker doublecortin (Dcx) and the number of Dcx-positive *Department of Neurosurgery, Rush University Medical Center, cells and the extent of cell migration quantified. Neuronal differentia-Chicago, IL, USA tion was examined 8 weeks after AAV 1/2 injection by investigating the †Department of Pharmacology, Rush University Medical Center, degree of colocalization for BrdU and neuronal markers including Chicago, IL, USA NeuN, calbindin, and DARPP32. We observed no difference in the number of Dcx-positive cells within the striatum of AAV 1/2 -IGF-1 and AAV 1/2 -Luciferase-treated animals 4 weeks after viral vector injection.
The present series of studies was undertaken to determine the viability and potential for hematopoietic human umbilical cord blood In contrast, the number of Dcx-positive cells, and the extent of their migration into the striatum, were significantly increased in AAV 1/2 -cells (hUCB cells), either in their heterogeneous or directed form towards a DA phenotype, to repair, replace, or regenerate the loss of IGF-1-treated animals compared to control animals 8 weeks after injection. A small proportion of these cells was found to double label DA in the striatum of Parkinsonism-like rats pretreated with the DA neurotoxin, 6-hydroxydopamine. Presently, there has been one pub-with BrdU/NeuN. These results demonstrate that IGF-1 can redirect the migration of neural progenitor cells from the SVZ/RMS into the lished study transplanting hUCB cells into an animal model of PD, in which the life span of PD mice was extended compared to PD mice normal adult rat striatum and may have potential in enhancing progenitor cell migration to sites of brain injury.
receiving congenic bone marrow cells or no treatment (Ende, 2002) .
hUCB cells are well established and a reliable source of a heteroge-On the other hand, graft-derived neurons also expressed more mature neural markers such as DARPP-32, NeuN, calretinin, and somatostatin neous population of cells that are known to be rich in hematopoietic stem and progenitor cells (Broxmeyer, 1996; Mayani and Lansdorp, clearly identified by a combination of immunohistochemistry with fluorescence in situ hybridization. Notably, certain subtypes of striatal 1998). In addition, these cells are simple to obtain with virtually an unlimited supply of cells that can be easily preserved and available for neurons could not be detected within the graft area (parvalbumin, ChAT) and the cellular phenotype of most differentiated graft-derived transplantation at any time. The advantage of the high yield of these stem cells dovetails nicely with the ability to cryopreserve cord blood neurons retained more immature features than their host counterparts at 6 months posttransplantation. Importantly, host-derived tyrosine cells for an indefinite period, which is an essential prerequisite for any cell-based therapy. With proper handling and processing cryopreserva-hrydroxylase (TH) fibers of the intrinsic nigrostriatal projections pathway had already heavily innervated the grafted areas and formed syn-tion does not substantially affect the viability of the cells and frozen cord blood cells have maintained their viability and proliferation ca-aptic contacts with DARPP-32-positive striatal neurons, as revealed by a coexpression of TH and synaptophysin. The overall immuno-pacities for as long as 15 years. The mononuclear fraction of hUCB cells in cell replacement/repair studies has been used with either the logical host response in the grafted area under continuous triple immunosuppression medication was only modest with no signs of graft heterogeneous or the predirected population. While these cells encompass many attractive properties, the most advantageous is their im-rejection. However, this was contrasted by a localized increase of immunocompetent host cells (CD45+, CD4+, CD8+ lymphocytes) within mune immaturity, which directly relates to a low incidence of graft versus host disease and therefore a low rejection rate in transplants.
the perivascular cuffs. Concluding, this study demonstrates for the first time the dynamic cytoarchitectonic picture of human fetal striatal Although cord blood cells are considered adult cells, their initial expression is that of immature cells. Additionally, these cells have sev-transplants in HD 6 months after grafting and provides for a better understanding of the complex developmental aspects involved in fetal eral advantages over the other human cell sources because of their innate characteristics, which include less B-cell production of IgG or neural and potentially also stem cell transplantation approaches. IgA and T-cell function in cord blood than in adult blood (which means the host is less likely to form an attack against hUCB cells).
Telomeric analysis demonstrates cord blood cells to have longer telo-Neuronal Differentiation of Human Mesenchymal Stem Cells meres than other cell types, including adult bone marrow cells (thus
Is Dependent on the PKA Pathway and Intracellular Ca 2+ allowing for a greater number of cell cycles), markedly lower production of cytokines than in adult blood cells, which directly relates to lower inflammatory response, immune immaturity and host nonrecog-G. Nikkhah,* C. E. Jannes,* A. Papazoglou,* A. T. Mehlhorn, † nition, and the volume of stem/progenitor cells are reportedly higher S. Kaiser, ‡ M. J. Teixeira, § S. K. N. Marie, ¶ J. Bischofberger,# in hUCB cells than bone marrow and peripheral blood cells. This preand G. Lepski* sentation will elucidate on the multitude of factors that may be involved in the transplantation of hUCB cells in PD, and specifically the *Department of Stereotactic and Functional Neurosurgery, results of our studies that transplanted these cells into PD-like rodents.
Neurocenter The differentiation of mature neurons derived from mesenchymal ‡Department of General Pathology, University of Freiburg, stem cells (MSCs) has opened up novel alternatives for cell resources Frieburg, Germany implied in the development of neural restorative approaches for diseases of the central nervous system. However, previous experiments §Department of Neurology, University Hospital Ulm, Ulm, Germany have utilized coculture systems, thereby raising the possibility that expression of neuronal markers resulted from cellular fusion of MSCs Fetal stem cell (FSC) transplantation is a promising novel therapeutic approach that has the potential to replace damaged host striatal with mature neurons already present in feeder layers. Therefore, in this study MSCs were isolated from adult human bone marrow and neurons and, thereby, slow down or even reverse clinical signs and symptoms during the otherwise fatal course of Huntington's disease characterized by FACS and grown without any feeder layers. Cell differentiation was induced by culture medium containing either cAMP, (HD). Open labeled clinical trials with fetal neural transplantation for HD have demonstrated long-term improvement and stability of some IBMX, BDNF, combinations of the three, or no cytokines. A variety of Ca 2+ channel blockers or protein kinase A inhibitor (PKAi) were clinical symptoms paralleled by a progressive worsening of other parts of HD. Therefore, further progress will depend on a better understand-used to impair differentiation, and NF200 immunostaining was used to quantify the results. Patch clamp recording was used to confirm the ing about the mechanisms of cellular and molecular graft-host interactions, including the time course and extent of cell survival, maturation, neuronal phenotype. Control cells were not positive for NF200. On the other hand, 10.75 ± 1.35% (p < 0.0001) of the cells were NF200 and integration, as well as potential host versus graft rejection processes. Here we report on the immunohistological evaluation of a HD positive after IBMX was added the culture medium, and 15.18 ± 1.12% were NF200 positive after a combination of cAMP and IBMX patient who died 5 and 6 months, respectively, after stereotactic implantation of human fetal-derived ganglionic eminence tissue into the was added (p < 0.0001). Na + and K + voltage-gated currents were recorded, but action potentials were not observed. Differentiation was left and right caudate putamen (neostriatum). Both striatal engraftment sides showed macroscopically clear strands of grafted tissue that were impaired by PKAi (5.73 ± 0.42%, p < 0.0001), nifedipin (5.79 ± 0.98%, p < 0.0001), Ni (7.06 ± 1.68%, p < 0.0001), and Cd (0 ± 0, p well integrated along the implantation tracts into the host brain parenchyma. A detailed immunohistochemical analysis revealed a complex < 0.0001). Taken together, neuronal differentiation of MSCs could be successfully induced in the absence of feeder layers and seems to de-picture of immature neuroepthial phenotypes (doublecortin, Sox2+, Prox-1, β3-tubulin), pronounced migration into the surrounding host pend on the PKA pathway and intracellular concentration of Ca 2+ . Further understanding of the underlying mechanisms that govern MSCs striatal tissue, and still considerable mitotic activity (Ki67, MCM2).
differentiation towards a stable neuronal phenotype provides a unique
In advanced Parkinson disease (PD) there is marked loss of dendritic spines on striatal medium spiny neurons (MSNs), with similar opportunity to enhance our understanding of stem cell plasticity and, at the same time, to foster the development of stem cell-based restorative pathology observed in parkinsonian mice and rats. Administration of the calcium channel antagonist nimodipine prevents spine loss despite transplantation strategies for neurological diseases.
severe DA depletion in rats (Day, 2006) . The impact of dendritic spine loss on motor deficits in PD has not been studied. We compared motor deficits in severely DA-depleted rats implanted with nimodipine pel-Peripherally Administered Human Umbilical Cord Blood lets (to prevent spine loss) to vehicle pellet control rats (with dendritic Cells Reduce Parenchymal and Vascular ␤-Amyloid Deposits spine loss). Male Sprague-Dawley rats received continuous release niand Suppress CD40-CD40L Interaction modipine (0.8 mg/kg/day) (6-OHDA + Nimod) or vehicle pellets (6-OHDA + vehicle) 2 days after 6-OHDA-mediated DA depletion. W. V. Nikolic,* H. Hou,* T. Town, † Y. Zhu,* B. Giunta,* Golgi-Cox staining and quantification of dendrite spine density con-C. D. Sanberg, ‡ J. Zeng,* D. Luo,* J. Ehrhart,* T. Mori,* § firmed prevention of spine loss with nimodipine in our model (6-P. R. Sanberg, ¶ and J. Tan* ¶ OHDA + vehicle-distal spine density: 5.83 ± 0.70*, proximal: 7.02 ± 0.84*; 6-OHDA + Nimod-distal: 8.00 ± 0.61, proximal: 9.48 ± 0.86; *Rashid Laboratory for Developmental Neurobiology, Silver Child intact striatum-distal: 11.14 ± 0.55, proximal: 13.04 ± 0.61; *p < 6-Development Center, Department of Psychiatry & Behavioral OHDA + vehicle vs. intact striatum). Two sensorimotor tests, forelimb Medicine, University of South Florida, Tampa, FL, USA use for weight shifting and postural support during exploration of a cylindrical enclosure and vibrissae-guided forelimb placing, were used †Maxine Dunitz Neurosurgical Institute and Department of to begin to understand whether loss of spines impacted various basal Biomedical Sciences, Cedars-Sinai Medical Center, Los Angeles, ganglia motor functions in a rat model of PD. Behaviors were evalu-CA, USA ated over 8 weeks. In the forelimb placing task, a test of sensorimotor ‡Saneron CCEL Therapeutics, Inc., Tampa, FL, USA integration, there was significant improvement in drug-naive perfor- §Institute of Medical Science, Saitama Medical School, mance in nimodipine-treated rats (week 1: 0/10 successful paw re-Saitama, Japan sponses; week 8: 3.6 ± 1.7/10; p = 0.004). In contrast, 6-OHDA + ve- ¶Center of Excellence for Aging and Brain Repair, Department hicle rats showed continued impairment with no improvement over of Neurosurgery, University of South Florida, Tampa, FL, USA time (p = 0.773). Forepaw use preference during vertical exploration of a cylindrical enclosure was not improved by spine preservation in Modulation of immune/inflammatory responses by diverse strateparkinsonian rats on this particular motor task (nimodipine week 1 vs. gies including amyloid-β (Aβ) immunization, nonsteroidal anti-inflamweek 8: p = 0.67; vehicle week 1 vs. week 8: p = 0.52; nimodipine vs. matory drugs, and manipulation of microglial activation states has vehicle p = 0.105). Dopamine receptors are located primarily on the been shown to reduce Alzheimer's disease (AD)-like pathology and neck of striatal MSN dendritic spines, and the number of these recepcognitive deficits in AD transgenic mouse models. Human cord blood tors decreases with increasing severity of PD (e.g., Wang, 2002) . To cells (HUCBC) have unique immunomodulatory potential, and we examine whether maintaining dendritic spine number would allow for wished to test whether these cells might alter AD-like pathology after improved therapeutic efficacy of antiparkinsonian drugs, we chalinfusion into the PSAPP mouse model of AD. Here, we report a lenged rats with the DA agonists pergolide (0.5, 0.25, 0.05 mg/kg), marked reduction of Aβ levels/β-amyloid plaques and associated apomorphine (0.05 mg/kg), or levodopa (12.5 mg/kg). Neither pergolastrocytosis following multiple low-dose infusions of HUCBC.
ide nor apomorphine, at the doses tested, improved performance in HUCBC infusions also reduced cerebral vascular Aβ deposits in the either behavioral test regardless of spine integrity (treatment vs. time, Tg2576 AD mouse model. Interestingly, these effects were associated nimodipine vs. vehicle, 1 week vs. 8 weeks postlesion, all p > 0.05). with suppression of the CD40-CD40L interaction as evidenced by
In contrast, high-dose levodopa administration lead to significant imdecreased circulating and brain soluble CD40L (sCD40L) and elevated provement in the forelimb placing task performance in rats with desystemic IgM levels, attenuated CD40L-induced inflammatory repleted dendritic spine density (p = 0.001); however, there was no fursponses, and reduced surface expression of CD40 on microglia. Importher improvement in task performance by rats with preserved striatal tantly, deficiency of CD40 abolishes the effect of HUCBC on elevated spine density (p = 0.246). In conclusion, the specific improvement in plasma Aβ levels. Moreover, microglia isolated from HUCBC-infused sensorimotor integration activity in an environment of preserved stria-PSAPP mice demonstrated increased phagocytosis of Aβ. Further, sera tal dendritic spine density, despite severe nigral cell loss (99.65 ± from HUCBC-infused PSAPP mice significantly increased microglial 0.13% loss of TH+ cells), suggests that maintaining spine density is phagocytosis of Aβ 1-42 peptide while inhibiting IFN-γ-induced microgone critical component in improving some aspects of motor dysfunclial CD40 expression. Increased microglial phagocytic activity in this tion in parkinsonian subjects. Further, these behavioral findings supscenario was inhibited by addition of recombinant CD40L protein.
port the hypothesis that multiple signaling pathways in addition to do-These data suggest that HUCBC infusion confers mitigation of ADpamine are involved in complex motor behaviors related to PD. like pathology by disrupting CD40L activity. (SCI) at low thoracic levels in rodents and the effects of treatment T. Schallert, ¶ and K. Steece-Collier* strategies, hind limb locomotor function is of key importance. However, to monitor sensory functions, behavior observations are less well *Department of Neurology, University of Cincinnati, Cincinnati, suited in SCI experiments, because they typically rely on limb or tail OH, USA movements, making it difficult to separate sensory from motor defi- †Department of Psychology, University of Texas at Austin, Austin, cits. To overcome this problem, we use fMRI to monitor spinal cord and brain responses to limb stimulation. Strikingly, we previously TX, USA 478 ABSTRACTS found that rats subjected to weight-drop injury of the spinal cord are ride (AMI; tricyclic that equally blocks norepinephrine and serotonin reuptake) or saline for a period of 6 weeks, beginning 2 weeks prior to able to recover hind limb locomotion to near-normal BBB locomotion scores (Basso et al., J Neurotrauma 12:1, 1995) , suggestive of sensory unilateral 6-OHDA infusion into the striatum. Four weeks postlesion, animals were sacrificed and processed for immunohistochemistry. Un-as well as motor recovery, yet without significant fMRI evidence of sensory function (Hofstetter et al., Eur. J. Neurosci. 18:3061, 2003) .
biased stereological quantification of tyrosine hydroxylase (TH; DA marker) and NeuN immunoreactive (NeuN; neuronal marker) neurons We have since demonstrated that fMRI can be used to visualize all synaptic relay stations activated by sensory stimuli to the limbs, as the throughout the SN are currently under way. Preliminary counts from a random sampling (n = 4) of each group, performed by a blinded signals ascend along the neuraxis from the spinal cord to cortex cerebri (Lilja et al., 2006) . After complete low thoracic SCI, stimulation of a observer, show a trend (p = 0.07) toward a significant sparing of THimmunoreactive cells in the SN of rats that received chronic AMI hind limb will no longer elicit BOLD fMRI responses above the level of injury. However, the local BOLD response in the lumbar spinal treatment. Although preliminary, these results highlight the ability of nondopaminergic drugs, such as antidepressants, to induce endogenous cord will increase, suggesting plastic reorganization below injury (Endo et al., 2008) , which may underlie spasticity seen clinically. Stimulation changes within the basal ganglia that may protect dying or injured DA neurons. of the fore limb in the same complete SCI animals will elicit enlarged BOLD responses that expand into neighboring hind limb sensory terri-Supported by University of Cincinnati Millenium Fund (T.J.C.). tory. We have followed the time course of this cortical plasticity and found that it correlates to downregulation of key Nogo receptor genes NgR and Lingo and upregulation of BDNF in areas undergoing plastic changes. This is further evidence that downregulation of NgR is a necessary event of structural synaptic rearrangements in the CNS. Fi-Hematopoietic Growth Factors Enhanced the Contribution nally, we have begun to use MR proton spectroscopy to monitor chemof Bone Marrow Stem Cells in Neovascularization ical changes in response to SCI. We find partly opposite chemical and Neurogenesis During the Chronic Phase of Brain Ischemia changes in the spinal cord below injury compared to the brain (Erschbamer, Ö berg, Westman, Sitnikov, Olson, Spenger, unpublished We have previously demonstrated that systemic administration of K. L. Paumier, C. E. Sortwell, B. F. Daley, B. T. Terpstra, the hematopoietic growth factors (HGFs), stem cell factor (SCF) com-L. M. Madhavan, N. D. Levine, and T. J. Collier bined with granulocyte-colony stimulating factor (G-CSF), improves functional outcomes when administered during the chronic phase of Department of Neurology, University of Cincinnati, Cincinnati, brain ischemia. However, the mechanisms underlying HGF-induced OH, USA functional restoration remain mostly unknown. The purpose of this study was to determine the contribution of bone marrow stem cells (BMSCs) in neovascularization and neurogenesis, which may be en-There is considerable evidence that Parkinson's disease (PD) results from a combination of genetic determinants, environmental fac-hanced by SCF + G-CSF during the chronic phase of brain ischemia. C57BL mice were subjected to cortical brain ischemia. Ten weeks tors, and a failure of neuroprotective mechanisms. While current pharmacological therapies aim to restore dopamine (DA) tone in the later, mice bone marrow (BM) was destroyed by a lethal dose of Xray irradiation and reconstituted by the BM harvested from transgenic nigrostriatal system, they do not address the progression of the disease. Levodopa is highly effective as a symptomatic treatment in the early mice, which carry ubiquitously expressed green fluorescent protein (C57BL-GFP). Four weeks after BM transplantation, SCF + G-CSF or stages of PD; however, with long-term exposure, waning efficacy, and side effects become problematic. Therefore, a neuroprotective therapy an equal volume of PBS was administrated subcutaneously for 7 days. One day after the final injection, the level of mobilized BMSCs that prevents patients from reaching the advanced stages of the disease may provide a more thorough approach to PD treatment. To date, the (CD34 + /c-kit + ) in the peripheral blood was determined by flow cytometry. The penetration of BM-derived cells in the brain was detected most promising neuroprotective strategy has been the exogenous administration of neurotrophic factors in both preclinical and clinical with a 2-photon confocal microscope in live animals. Two months after treatment, mice were sacrificed for determination of BM-derived studies. Unfortunately, several failed clinical trials indicate a new approach for delivering these agents is necessary. The recently discov-cells in the brain by using immunohistochemistry. We observed that the levels of CD34 + /c-kit + cells in the blood were significantly in-ered trophic response to antidepressant treatment may provide an alternative means for increasing endogenous neurotrophic support within creased by HGFs treatment. In addition, in vivo brain imaging showed that numerous GFP + cells migrated into the brain parenchyma in the the basal ganglia, thus preventing or slowing the progression of PD. Antidepressants such as tricyclics and selective serotonin reuptake in-treated mice. Immunohistochemical study revealed that BM-derived neurons (NeuN + /GFP + ) were dramatically augmented, whereas BM-hibitors (SSRIs) have recently been shown to increase trophic factors such as GDNF and BDNF, which have been reported to attenuate the derived astrocytes (GFAP + /GFP + ) were reduced after HGFs treatment. We also found that BM-derived endothelial cells (PECAM + /GFP + ) lesion-induced loss of dopaminergic neurons in animal models of PD. However, most of these findings have been established within brain were significantly increased in the mice that received HGFs treatment. These data suggest that SCF + G-CSF can mobilize BMSCs to home regions involved in depression (mesolimbic), so little effort has been made to investigate the antidepressant-mediated trophic responses of into the brain and enhance the contribution of BMSCs in angiogenesis and neurogenesis during chronic phase of brain ischemia. The en-the nigrostriatal system. Therefore, the current study will detail the neuroprotective properties of antidepressant treatment in the nigrostri-hancement of BM-derived neurons and endothelia cells may be associated with SCF + G-CSF-induced functional restoration in chronic atal system. We hypothesize that antidepressant treatment prior to a striatal 6-OHDA lesion will increase endogenous trophic factor levels stroke. This study is supported by American Heart Association, Louisiana in the basal ganglia, thereby creating a neurotrophic-enriched environment that can ultimately protect the nigrostriatal pathway from neuro-Gene Therapy Research Consortium, CADASIL foundation of America, Franks Imaging Lab, and Malcolm Feist Endowment for Cardiovascu-toxic insult in a rodent model of PD. Forty adult male Wistar rats received either daily or weekly injections of amitriptyline hydrochlolar Research.
nicotine clinically should have greater efficacy in reducing neuroinflammation than either drug given alone. The present findings will *Division of Biological Research, H. Lundbeck A/S, Copenhagen, Denmark also help us determine the optimum dose range needed for a pivotal †Faculty of Biology, University of Konstanz, Konstanz, Germany study of these two compounds given chronically to double mutant (PSAPP) Alzheimer transgenic mice. Glycogen synthase kinase-3 (GSK3β) is involved in several neuro-This work was supported by NIH grant (5 R21 AG031037-02). pathological events associated with Alzheimer's disease (AD), including tau hyperphosphorylation. The present study applied a postnatal rat model of tau hyperphosphorylation to study the efficacy of dif-Histone Modifications in Differentiating Dorsal Root Ganglia ferent classes of small molecule GSK3β inhibitors such as arylindo-Neural Crest Stem Cells lemaleimide (SB216763), bis-indole (Indirubin-3-monoxime), aminopyrimidine (CHIR98014), thiazole (AR-A014418), and benzazepinone (Alsterpullone) in decreasing tau phosphorylation in vivo. Validation R. P. Singh,* J. Serak,* C. B. Anthony,* and F. C. Zhou* † of rat postnatal model by monitoring the levels of juvenile rat tau protein demonstrated a peak in tau phosphorylated at Ser202, Ser396, *Department of Anatomy & Cell Biology, Indiana University School Thr205, and Thr181 epitopes in the first 2 weeks of postnatal developof Medicine, Indianapolis, IN, USA ment in the rat, which decreased in adulthood. Likewise, the increased †Stark Neuroscience Research Institute, Indiana University School p-tau levels during early brain embryonic and postnatal development of Medicine, Indianapolis, IN, USA correlated with an increase in GSK3β enzyme activity. In this study we show that the efficacy of inhibitors on decreasing phopshorylation
We have previously demonstrated that alcohol exposure affected of tau isoforms at postnatal day 12 varied according to the inhibitors neural development by altered cell cycle and differentiation of neural used. Lithium and CHIR98014 reduced tau phosphorylation (Ser396) stem cells (NSCs) using dorsal root ganglia (DRG) as a model of fetal in postnatal rats in cortex and hippocampus, Alsterpaullone, and SB216763 alcohol syndrome. The mechanism by which alcohol affects the reguonly in the hippocampus. AR-A014418 showed no effect in either lation of the stem cell-ness and differentiation of the DRG NSC is not brain region at any time point tested. Inhibition of p-tau in brain reclear. Alcohol has been known to alter the methyl and acetyl donors quired several-fold higher exposure levels, than the IC 50 values obpotentially mediating histone modification in the epigenetic dynamic. tained in recombinant or cell-based GSK3β enzyme activity assays.
In this study, the epigenetic modifications (e.g., histone methylation Furthermore, we show that the observed reduction in p-tau levels roand acetylation) were studied. NSCs were subplated in 16-well chambustly correlated with the inhibition of enzyme activity by these inhibiber slides coated with poly-D-lysine and laminin. DRG NSCs differtors when administered into 12-day-old postnatal rats. The inhibitory entiated in neurobasal medium (B27 and fetal bovine serum) in the effect on GSK3 activity ex vivo and in vitro correlated with the inhibipresence or absence of 400 mg/dl alcohol for 2 or 4 days. Histone tor's neuroprotective and p-tau-reducing effects in vitro. A reduction methylation patterns were determined by fluorescence immunocytoin tau phosphorylation and a reduction of cytotoxicity at low µM conchemistry using antibodies against methylated histone H3 at lysine 4 centrations of inhibitors were also observed in a human neuronal cell (H3K4) (affiliated with euchromatin), H3K9 and H3K27 (affiliated line. These data suggest that GSK3β inhibition could be used as an with heterochromatin and transcriptional repression), and acetylated effective therapy to treat AD and related tauopathies where tau phos-H4 (affiliated with heterochromatin). The stem cell cultures were then phorylation is believed to contribute to disease pathogenesis.
double immunostained with slug, sox-9, and sox-10 for sensory stem cell markers, and with β-III-tubulin for neuronal differentiation markers. The intensity of sox-10 remained similar to controls at 2 days, but Nicotine/Cannabinoid Coadministration as a Possible Treatment decreased dramatically after 4 days of alcohol exposure. Intensity of for Neuroinflammation H3K4 declined sharply at 2 days. H3K27 declined at 4 days, compared to controls; H3K27 downregulated DRG NSCs differentiating into β-R. D. Shytle,* † ‡ J. Ehrhart, † ‡ J. Zeng, † ‡ P. R. Sanberg,* ‡ III-tubulin+ cells with synapses. Expression of acetylated H4 increased and J. Tan* † ‡ slightly at 2 days, but returned to near control levels at 4 days. The H3K9 and slug expression remained at low levels at both time points. *Center of Excellence for Aging and Brain Repair, Department
These results indicate that alcohol can alter the histone methylation of Neurosurgery of Medicine, Cincinnati, OH, USA (whole brain TNF-α in mice). Using our in vitro model of microglial ‡Departments of Pharmacology, Neurosurgery, and Psychiatry, activation, we found that the combination of nicotine (0.625-10 µM)
Yale University, New Haven, CT, USA and THC (0.625-10 µM) synergistically reduced LPS-induced cytokine release. Likewise, similar results were found in whole brain cytokine release when nicotine (0.25-1.0 mg/kg, IP) and THC (0.3-3.0
Our prior studies suggest that neurites from grafted mesencephalic tissue can extend from the rostral brain stem through the tegmentum mg/kg, IP) were administered in combination in vivo immediately prior to systemically administered LPS. These findings provide further to course in concert with ascending catecholamine pathways toward the desired target, the neostriatum, when provided with the attractant proof-of-concept for our hypothesis that the combination of THC and force of cografted embryonic striatal anlagen at distances of 2.5 and mine (6-OHDA) to induce a partial lesion of the nigrostriatal system. Immunohistochemical results 3 months after vector injection revealed 5.0 mm distal to the nigral grafts. Some fibers even reached the full distance of 7.5 mm between the grafted substantia nigra (SN) and host efficient gene transfer throughout a large region of the striatum as well as retrograde and anterograde transport to the substantia nigra pars neostriatum, albeit in small numbers. To test further the potential to resupply the host from grafted and/or residual dopaminergic (DA) neu-compacta (SNpc) and pars reticulata (SNpr), respectively. Quantitative analysis of PTN protein utilizing both enzyme-linked immunosorbent rons of the SN we devised a protocol for multiple striatal grafts to be placed along the trajectory of the nigrostriatal pathway at intervals of assay (ELISA) and Western blotting demonstrated that injections of rAAV2/1 PTN/GFP induce significantly higher PTN protein levels 2.5 mm. Thus, three striatal grafts were placed bilaterally into each of four adult, MPTP-treated host African green monkeys that also re-than are present in the nontransduced striatum. Stereological analysis of TH-ir SN neurons indicated that rats that received striatal injections ceived a SN graft placed immediately rostro-dorsal to the host SN. Animals were killed at 11.5 months after implantation and prepared of rAAV2/1 PTN/GFP possessed approximately twofold more SN DA neurons than rats that received control rAAV2/1 GFP reporter vector for tyrosine hydroxylase (TH) and dopamine transporter (DAT) immunochemistry. Histological analysis revealed two distinct findings. First, (p < 0.05). Further experiments were conducted to evaluate the impact of PTN gene transfer on forelimb akinesia in the cylinder task. At in two animals, striatal graft placements were as planned and stimulated the progressive growth of TH-and DAT-positive fibers from all time points after lesion control rats used their impaired forepaw significantly less for spontaneous exploration. In contrast, rats receiv-well-developed SN grafts, and possibly the residual SN neurons, to the host neostriatum where the dorsal and posterior quadrants were ing PTN vector exhibited significant recovery of impaired forepaw usage at 13 and 17 weeks after lesion with significant differences be-most prominently stained for DA fibers. The remainder of the host target was devoid of DA fibers. These striatal grafts appeared to be tween treatment groups observed 17 weeks postlesion (p < 0.05). Interestingly, while neuroprotection of SN DA neurons appears to occur relatively slender and showed dense, parallel arrays of TH fibers at their proximal and distal surfaces. The second finding encourages the relatively soon after lesion, neurorestoration of functionally relevant striatal dopaminergic neurotransmission occurs over a much longer view that the residual host SN can contribute to a neostriatal resupply because the SN grafts were modest in size and cell number, and the time course. This suggests that PTN may elicit sprouting of remaining dopaminergic terminals. Taken collectively, these data indicate that striatal grafts were incomplete along the trajectory, but robust within the neostriatum where two grafts of striatal tissue were found as a striatal PTN overexpression can provide significant neuroprotection in an animal model of parkinsonian insult. Continued studies will provide result of a more anterior directed placement. Again, the dorsal and posterior quadrants of the host target were heavily supplied with TH insight into potential of PTN gene transfer as a therapeutic strategy to treat PD. fibers. These findings suggest that DA fibers can be coaxed to resupply the DA-depleted host striatum and favor a view that a more neuro-Supported by The Michael J. Fox Foundation for Parkinson's Disease Research (C.E.S.) and NS058682 (C.E.S.) . anatomically correct microenvironment for SN grafts may be created through circuit reconstruction to aid future attempts at restoration of lost function in DA-depleted, nonhuman primate models of parkinsonism. High-frequency deep brain stimulation of the subthalamic nucleus †Neuroscience Graduate Program, University of Cincinnati, (HF STN-DBS) has become a routine surgical therapy for the treat-Cincinnati, OH, USA ment of Parkinson's disease (PD). However, the clinical use of this ‡Department of Neuroscience, University of Florida, Gainesville, treatment has proceeded without an understanding of its mechanism FL, USA of action. We therefore set out to develop a long-term, clinically rele- §Department of Psychiatry, University of Cincinnati, Cincinnati, vant model of HF STN-DBS for use in parkinsonian rats. We first OH, USA determined the area of current spread during stimulation of the STN by conducting in vivo simultaneous stimulation recording experiments. Results indicate that STN-DBS at routine clinical parameters (130 Hz, Trophic factors are normally involved in the development and maintenance of the nigrostriatal system, yet they also possess incredi-60 µs pulse width, 80 µA) causes current to spread approximately 250 µm from the stimulator tip. Subsequently, stimulators were placed in ble potential to repair it. Such trophic factors may have great potential as therapeutics in Parkinson's disease (PD) by providing long-term the anterior portion of the STN to minimize current spread to the substantia nigra (SN). We next wanted to establish a lesion protocol with efficacy without the disabling side effects associated with current treatments. Our laboratory and others have revealed that the trophic nigral dopamine (DA) neuron loss similar to symptomatic PD patients.
Establishment of a Clinically Relevant Model of Long-Term STN Deep Brain Stimulation in Parkinsonian Rats
We performed experiments examining differing unilateral intrastriatal factor pleiotrophin (PTN) is an important intrinsic factor for the development, maintenance, and repair of the nigrostriatal dopamine (DA) 6-hydroxydopamine (6-OHDA) lesion parameters. Rats were injected into two sites in the striatum with either 2 or 3 µl of 6-OHDA (5 µg/ system. PTN's role during development points to its potential to provide neuroprotection and promote reconstruction of nigrostriatal cir-µl) in either one discrete injection or an injection distributed 1.5 mm along the dorsal-ventral axis. Amphetamine-induced rotational asym-cuitry when used as an exogenous therapeutic. We previously reported that PTN gene transfer to the striatum of rats can provide neuroprotec-metry and degree of forelimb akinesia in the cylinder task were used to evaluate functional outcomes. Rats were sacrificed at 2, 4, and 6 tion in a rodent model of PD. Male Sprague-Dawley rats received stereotaxic injections to the striatum of recombinant adeno-associated weeks after lesion and processed for immunohistochemistry using antisera against tyrosine hydroxylase (TH). TH-immunoreactive (TH-ir) virus 2 serotype 1 (rAAV2/1) vector encoding either 1) PTN and green fluorescent protein (GFP) or 2) control vector encoding GFP only.
neurons in the SN were quantified using unbiased stereology. Our results identified one protocol that causes a progressive lesion (2 weeks = One month later all rats received striatal injections of 6-hydroxydopa-482 ABSTRACTS 50% SN lesion, 4 weeks = 70%, 6 weeks = 75%) and another a stable Several open label trials and numerous investigations in animal models have provided proof of principle that intrastriatal placement of lesion (2 weeks, 4 weeks, 6 weeks = 75% SN lesion), both of which generated significant deficits in forelimb akinesia and rotational asym-embryonic dopamine neurons can induce significant and long-lasting reversal of motor deficits in parkinsonian subjects. More recent pla-metry. Our final goal was to establish accurate, long-term stimulation of the STN in rats. Rats were unilaterally lesioned utilizing the pro-cebo-controlled clinical trials have failed to find consistent or statistical improvement of primary endpoints, and have noted the develop-gressive lesion protocol and implanted with bipolar concentric stimulating electrodes utilizing extracellular recording-guided placement. ment of severe off-phase dyskinesias in a subset of graft recipients. There are many factors associated with late stage Parkinson's disease Following a 2-week recovery period, continuous stimulation was initiated for 2 weeks (130 Hz, 60 µs pulse width, 50-100 µA). Histologi-that are likely to impede success of embryonic cell transplantation, as well as numerous other experimental strategies aimed at replacing or cal analysis revealed accurate targeting of the STN with the stimulating electrode that lasted the entire 4-week postimplantation interval.
restoring Umeå, Sweden Cincinnati has developed a Brain Awareness Week curriculum de- †Department of Anatomy and Neurobiology, University of Kentucky, signed to be a hands-on interactive approach to teaching the study of Lexington, KY, USA the brain to kids from kindergarten through college. A school fair-like ‡Department of Physiological Sciences, Lund University, Lund, atmosphere comprised of different "booths," staffed by neuroscience Sweden professionals and graduate and postgraduate trainees, primarily focuses on four aspects of the study of neuroscience. 1) The first aspect In Parkinson's disease, patients develop motor complications after focuses on the variety of careers in the field of neuroscience and prolong-term L-dopa treatment. About 40% of the parkinsonian patients vides insight into types of neuroscience research performed in the labbecome dyskinetic within 4 years of L-dopa treatment, and the incioratory. Insight and information from resources, including NIH, on dence continues to increase over time. Thus, the patients become sehow to discuss the benefits and controversies of animals in research is verely affected by the therapy. It is believed that dyskinetic behavior provided. 2) The second aspect focuses on general brain health. Examis because L-dopa is, to a higher extent, converted to dopamine and ples of tools for this aspect will be showcased and include posters released from serotonergic rather than from dopaminergic nerve fibers. about diseases of the brain, models of diseased brain, x-rays and scans
In this study, chronic treatment of L-dopa in unilaterally dopamineof brains following trauma, and information on nutrition that promotes depleted rats demonstrated that 5-HT nerve fiber density, as visualized brain function. 3) The third aspect focuses on anatomy of the brain, with SERT-immunohistochemistry, was significantly higher in dyskiwhich is illustrated using various hands-on models of the whole brain, netic than in nondyskinetic animals. Moreover, in vivo chronoamperothe limbic system, the ventricular system, and the brain stem. This metry was used to study the conversion of L-dopa to dopamine locally aspect is also covered by showing students a phylogenetic comparison in the striatum. Using this method, dopamine and serotonin can be of brains of different species including human (plastinated), sheep, readily monitored, while L-dopa cannot be detected. The results redog, hamster, rat, and frog. Laptop computers are used where children, vealed that local application of L-dopa increased potassium-evoked with the assistance of staff, can explore animations of brain anatomy, dopamine release in intact striatum, while chronic L-dopa treatment inside and out. 4) The fourth and final aspect of this educational projreduced the amplitude of released dopamine in intact striatum. Furtherect is related to the functional aspects of the brain. Functional aspects more, in dopamine-depleted striatum, dopamine was released upon loof brain are illustrated using interactive games focusing on perception cal application of L-dopa, often several minutes after the L-dopa loadand concentration, sensory information, sleep, sidedness, and reflexes, ing. Under special conditions, however, extracellular dopamine could as well as an interactive snap-circuit board to illustrate the role of be monitored already a few seconds after L-dopa injection, indicating synapses in neural communication. This curriculum for the University that L-dopa was converted in cells other than neurons. In conclusion, of Cincinnati's Brain Awareness Week has been designed to provide local loading of L-dopa into dopamine-depleted striatum takes two an effective and fun way of learning and teaching about the imporroutes when being converted to dopamine, either direct conversion tance of the brain and brain research.
without loading into nerve fibers or by loading into nerve fibers. for the passage of molecules but prevents cell-cell contact. In addition, some of the neurons/slices received MSC-or MSC-NPC-condi-Amyotrophic lateral sclerosis (ALS) is a fatal neurodegenerative tioned medium (neuronal/slice medium cultured with MSC-NPCs for disease causing the progressive loss of brain and spinal cord motor 24 h). Cell damage/death was assessed by quantifying lactate dehydroneurons. Stem cell-based transplantation is a valuable method for drug genase (LDH) release and normalizing to the control conditions. At delivery as these cells migrate and integrate into the damaged nervous 24 h post-OGD, there was a significant reduction in LDH release from system. Furthermore, they can be genetically modified to release neurons and slices co-cultured with either MSCs or MSC-NPCs comgrowth factors and thus act as long-term "minipumps." We previously pared to those cultured with normal media only (p < 0.05). Furtherestablished stable, expandable lines of genetically modified human more, at 24 h post-OGD, there was a significant reduction in LDH neural progenitor cells (hNPC) releasing glial cell line-derived neurorelease from neurons cultured with either MSC-or MSC-NPC-conditrophic factor (GDNF) and transplanted them into two segments of the tioned media compared to those cultured with normal media only (p < lumbar spinal cord in a rat model of ALS (SOD1 G93A rats). Our most 0.05); and the rescue effect of the conditioned media was dose depenrecent data (Suzuki et al., PLoS One, e689, 2007) suggested that at dent. There was also a modest reduction in LDH release at 24 h postearly stages of disease there was robust cellular migration into degen-OGD for slices cultured with either MSC-or MSC-NPC-conditioned erating regions, efficient delivery of GDNF and remarkable preservamedia compared to those cultured with normal media only. Thus, both tion of host motor neurons. However, this robust motor neuron sur-MSCs and MSC-NPCs were able to rescue injured neural cells without vival was not accompanied by continued innervation of muscle end cell-cell contact, likely through the secretion of trophic factors. This plates and thus resulted in no improvement in ipsilateral limb use. In study emphasizes the importance of trophic support provided by bone the present study we performed intramuscular transplantation with humarrow-derived stem cells, which may contribute to the efficacy of man mesenchymal stem cells (hMSC) to deliver growth factors to the cell transplants as a therapy following in vivo brain injury. terminals of motor neurons as well as the skeletal muscles. hMSC releasing GDNF (hMSC-GDNF) were transplanted into the limb muscles of ALS rats at 80 days. These cells could survive, release GDNF, and have significant effect on the innervation of neuromuscular con-Neuroprotective Potential of Peripheral Inosine Administration nections in the transplanted muscles at 6 weeks postsurgery. Furtherin Parkinsonian Rats more, intramuscular transplantation with hMSC-GDNF could ameliorate motor neuron loss within the spinal cord, which connected to the B. T. Terpstra, J. W. Lipton, K. L. Paumier, N. D. Levine, A. Yu, limb muscles with transplants. Finally, we checked whether intramus-V. B. Thompson, S. L. Wohlgenant, and C. E. Sortwell cular hMSC-GDNF transplantation could prolong survival in ALS rats. When the animals were left until endpoint, there was a significant Department of Neurology, University of Cincinnati, Cincinnati, effect in the hMSC-GDNF transplanted rats on survival period by ϳ18 OH, USA days compared with control littermates. Taken together, combining cell replacement with localized growth factor delivery targeting the Parkinson's disease is characterized by a progressive loss of dopaspinal cord represents a unique way to prevent motor neuron loss in mine (DA) neurons in the substantia nigra (SN) pars compacta, resultthis model of familial ALS, but additional strategies are likely to be ing in decreased levels of DA in the striatum. At present, there is required for maintenance of neuromuscular connections. These preno neuroprotective therapy available to PD patients. Inosine, a purine clinical data will provide a novel approach towards ex vivo gene thernucleoside that readily crosses the blood-brain barrier (BBB), has apy targeting to both the skeletal muscle (i.e., nerve terminals of motor been shown to possess neuroprotective properties against ischemia in neurons) and spinal cord (i.e., cell body) for future human clinical vivo (Shen et al., 2005) . We previously demonstrated that inosine is studies.
Why Hasn't Neural Transplantation for Parkinson's
neurotrophic for DA neurons in vitro. Mesencephalic cell suspensions This work was supported by the grant from the ALS association, derived from E14 Sprague-Dawley rats were plated at a concentration NIH/NINDS (NS057778), the University of Wisconsin Foundation, and of 3000 cells/µl. Cultures were subjected to daily inosine treatment the Les Turner ALS foundation.
(0.5-4 mM) and evaluated under two separate cell culture paradigms: inosine added at plating or 24 h prior to and following a 6-hydroxydopamine (6-OHDA) insult. After the cessation of inosine administra-Human Bone Marrow-Derived Stem Cells Rescue Neural Cells tion, immunocytochemistry for tyrosine hydroxylase (TH) was per-
Following In Vitro Ischemia
formed. At all doses tested, inosine added at plating increased the survival of TH-positive neurons compared to controls (p < 0.0001). C. C. Tate, C. Fonck, M. McGrogan, and C. C. Case
Additionally, 2 and 4 mM inosine augmented survival to a greater extent than 0.5 or 1 mM. Furthermore, treatment with 2 and 4 mM SanBio, Inc., Mountain View, CA, USA inosine also protected TH-positive neurons from 6-OHDA administration (p = 0.01). In the present study, we established the parameters necessary to evaluate the potential of inosine to provide neuroprotec-Cell transplantation is a promising treatment strategy for many neurological disorders, including stroke, because of the ability to sup-tion in vivo. We first evaluated whether peripheral administration of inosine leads to increased levels of inosine in the SN and striatum. ply multiple therapeutic mechanisms to a defined site in a sustained fashion. Adult bone marrow-derived mesenchymal stem cells (MSCs) Rats received 250 mg/kg of inosine (SC) or an equal volume of vehicle and were sacrificed by intracardial saline perfusion at either 10 or are an attractive cell candidate for a number of reasons, including sufficient availability and the ability of these cells to differentiate along 20 min postinjection. Brains were collected and immediately flash frozen with the SN and striatum microdissected for analysis via HPLC. neural lineages in the appropriate environment. Transplantation of these cells has been shown to improve functional recovery following A single injection of inosine resulted in a 1-fold and 1.5-fold increase of inosine within 10 min of administration in the SN and striatum, experimental focal ischemia in rodents. Donor cells are likely to help the injured tissue through multiple mechanisms such as cell replace-respectively (p = 0.0002). This increase persisted for 20 min postinjection (p = 0.04). We next investigated how to accurately model primate ment and trophic support. Here, we investigated the ability of MSCs inosine metabolism in rodents. In primates the end product of inosine metabolism is uric acid, which is a potent antioxidant and anti-inflam-Department of Pharmacology, FMHS, University of Auckland, Auckland, New Zealand matory. However, in rodents the enzyme urate oxidase further metabolizes uric acid to allatoin. Therefore, we administered potassium oxo-Cell replacement therapy through transplantation may offer a vianate (K + O), a potent inhibitor of urate oxidase, to rodents at varying ble treatment strategy for patients with neurodegenerative disorders by concentrations in order to prevent the breakdown of uric acid. Plasma providing new cells to replace those lost through disease. Developing levels collected from rats revealed that uric acid levels comparable to effective transplantation strategies requires investigation and optimizathose in human (4-6 mg/dl) could be achieved in rats utilizing subcution of multiple parameters, particularly in the emerging field of stem/ taneous implants of K + O pellets. Ongoing experiments will determine progenitor cell transplantation. This study aimed to develop upon the whether daily peripheral injections of inosine to K + O rats can provide potential of adult neural progenitor cell (aNPC) transplantation in the protection of the nigrostriatal system from 6-OHDA lesion.
quinolinic acid (QA) lesion model of Huntington's disease by looking Supported by University of Cincinnati Millenium Fund (C.E.S.) .
at 1) in vitro neuronal priming of aNPC and 2) posttransplant environmental enrichment. Neural progenitor cells isolated from the subventricular zone of adult rats were propagated and labeled in vitro before transplantation into the QA-lesioned rat striatum, 3 weeks after lesion-Intrathecal Transplantation of GABAergic Human Neuronal Cell ing. Rats received transplants of either normal nonprimed aNPCs or Line for Treatment of Neuropathic Pain After Chronic aNPCs primed using an in vitro priming protocol that significantly Constriction Injury of the Sciatic Nerve (p < 0.01) enhances in vitro neuronal differentiation of aNPCs. Rats were housed in either standard or enriched conditions for 12 weeks L. Vaysse,* S. Jozan,* Y. Lazorthes,* M. J. Eaton, † and J. C. Sol* after transplantation. The rats underwent cylinder and corridor motor function tasks throughout the study to elucidate the functional effects *Laboratoire Approches expérimentales et Thérapeutiques des of priming and enrichment and their potential synergy. Fluorogold indouleurs neuropathiques, Faculté de Médecine Rangueil, Toulouse, jections into the globus pallidus were used to determine the ability of France transplant-derived neurons to develop appropriate efferent connections from the lesioned striatum. We present data of survival, differentiation †VA Medical Research Center, Miami, FL, USA and motor function after aNPC transplantation showing long-term sensorimotor benefits in QA-lesioned rats in both cylinder and corridor Chronic neuropathic pain after nerve injury is a common symptom tasks. Onset of sensorimotor improvements can be accelerated by in in clinical practice. Patients with chronic pain are subject to a greatly vitro priming prior to transplantation. The results of this study demonimpaired quality of life and, unfortunately, generally fail to respond to strate the potential of aNPCs for use in cell replacement therapy and conventional pharmaceutical treatments. Neuropathic pain is a very aids in the development of novel therapeutic strategies for the treatcomplex disease, involving several molecular pathways. Current unment of neurodegenerative diseases such as Huntington's disease. derstanding of induction and maintenance of chronic pain suggests a decrease of the inhibitory neurotransmitter GABA (gamma-aminobutyric acid) level in the spinal dorsal horn causing an imbalance be-Primed and Nonprimed Human Embryonic Stem Cell-Derived tween the excitatory and inhibitory pathways. Intrathecal grafting of Neural Precursor Transplantation Into the Quinolinic Acid cells as biological pumps to provide different antinociceptive mole-Lesion Rodent Model of Huntington's Disease cules have offered a new direction in the treatment of chronic pain. However, one major problem is the lack of a homogeneous, expandable cell source to supply the antinociceptive agents. A subcloned de-E. M. Vazey,* M. Dottori, † P. Jamshidi, † M. F. Pera, † M. Horne, ‡ rivative of the human NT2 cell line, which differentiates to a neuronal and B. Connor* phenotype that secretes inhibitory neurotransmitters such as GABA and glycine, has been recently isolated. These cells could represent a *Department of Pharmacology, FMHS, University of Auckland, new source for pain treatment. In the present study, we have evaluated Auckland, New Zealand the effects of hNT2.17 GABA cell transplant in a rat model of neuro- †Monash Institute of Medical Research, Monash University, pathic pain induced by unilateral chronic constriction injury (CCI) of and the Australian Stem Cell Centre, Victoria, Australia the sciatic nerve. This model is associated with a loss of GABAergic ‡Howard Florey Institute of Experimental Physiology and Medicine, inhibition in the superficial dorsal horn of the spinal cord and induced University of Melbourne, Parkville, Australia spontaneous and evoked behaviours associated with neuropathic pain. Differentiated hNT2.17 cells were transplanted into the lumbar subarachnoid space 2 weeks after CCI. The behavioral response to thermal Human embryonic stem cells (hESCs) may serve as an unlimited hyperalgesia and tactile allodynia in the hindlimbs was observed and source of any cell type in the human body, potentially providing a recorded during 4 weeks postsurgery. Transplant of hNT2.17 GABA renewable source of cells for use in transplantation therapy. The feasicells after CCI significantly reduces tactile allodynia and thermal hybility of transplantation therapy in the central nervous system (CNS) peralgesia whereas grafts of the negative control do not affect the deusing hESCs relies on the in vitro production of neural precursors velopment of neuropathic pain. We also determined that transplanted (NP). Recent research has identified an efficient method for deriving cells could survive more than 4 weeks postintrathecal implantation NP-rich cultures from hESCs involving the addition of the bone morand still present a GABAergic phenotype. These results suggest that phogenic protein antagonist noggin (Pera et al., 2004) . This study ex-hNT2.17 GABA cells may modulate pain generation after sciatic nerve amined the potential therapeutic use of hESC-derived NP cells as a constriction and are consistent with recent studies showing the theracell source for transplantation therapy for Huntington's disease (HD). peutic efficacy of hNT2.17 GABA cells in another rodent neuropathic
We evaluated the characteristics of noggin-induced and spontaneously pain model. Intrathecal transplant of hNT2.17 GABA cells, which can derived NP cells at various time points after transplantation into the be obtained easily in large quantities, may represent a promising alterquinolinic acid (QA) lesion rat model of HD. NP cultures were derived native for the treatment of human neuropathic pain. from the hESC line Envy (Costa et al., 2005) and cultured in a chemically defined medium with or without noggin. Unilaterally QA-lesioned adult male Wistar rats received a transplant of either noggin-induced or spontaneously derived Envy NP cells. Immunohistochemical and Effects of Environmental Enrichment and Priming of confocal analysis of brain sections demonstrated that Envy NP cells Transplanted Adult Neural Progenitor Cells on Functional survived and continued to express green fluorescent protein (GFP) Recovery in an Animal Model of Huntington's Disease within the QA-lesioned rat brain following transplantation. NP cells also migrated extensively within the QA-lesioned striatum. Fluorescent immunohistochemical analysis showed that some transplanted E. M. Vazey and B. Connor Envy NP cells differentiated into mature neurons, as demonstrated by for examining specific cellular and molecular mechanisms that control the behavior and dopaminergic differentiation of neurospheres in vivo. MAP2 and NeuN coexpression. Maturity was further demonstrated with the identification of graft-derived neural processes in the globus Research supported by the IRP of NIDA, NIH, DHHS. pallidus. Additional studies are investigating the functional effect of transplanted NP cells following QA lesioning using a range of sensorimotor tests. This study demonstrates the potential use of hESC-derived after, barometric plethysmography was employed at routine intervals MD, USA to assess the pattern of ventilation. This analysis revealed no group differences until 12 weeks posttransplantation, at which time FSCV Neural precursor cells (NPC) derived from human embryonic stem graft recipients exhibited larger tidal volumes (TVs) than either FSCD cells (hESCs) provide an unlimited source of cells that can potentially or FSCW graft recipients under quiet room air breathing conditions. be used in transplantation studies to treat diseases associated with loss Additionally, FSCV graft recipients exhibited a lower frequency of of cell function, such as Parkinson's disease. Utilization of NPC for breaths. As expected, no significant change in minute ventilation was transplantation therapy depends on the capacity of these cells to differobserved. Neurophysiological data confirmed the plethysmography reentiate into specific neural cell lineages. The present study describes sults, showing a trend towards greater amplitudes of neural output in the generation of mecencephalic-restricted human NPC from the hESC FSCV graft recipients. In other studies, we have found that FSCV line BG01 under the influence of stromal-derived inducing activity grafts consist of cells primarily resembling intermediate gray interne-(SDIA). SDIA (Kawasaki et al., 2000) refers to the property of certain urons, whereas FSCD grafts are comprised of matured substantia gelastromal cell lines, especially PA6, to induce dopaminergic neurogentinosa-like regions that are minimal at most in FSCV transplants. In esis directly from ESCs. When BG01 cells were cocultured with PA6 that context, these findings suggest neuronal specificity in promoting cells, 70 ± 15% of colonies contained tyrosine hydroxylase (TH)-posidifferences in certain aspects of respiratory behavioral recovery in this tive neurons after 12 days. At this time, cells within the majority of neuroplasticity model. To better understand the mechanisms involved, colonies showed typical neural precursor cell morphology with expreswe are employing neuroanatomical tracing methods to determine the sion of the early neuronal marker PSA-NCAM and the mesencephalic degree to which these results reflect integration of donor neurons into progenitor marker Msx1. NPC were isolated from the PA6 cells after the surrounding host circuitry at the level of the phrenic nucleus. Fur-10-12 days of coculture using papain, and propagated on a nonadhether, we are using neuronal phenotypic markers to identify which spesive substrate in a proliferative media comprised of DMEM/F-12, N2 cific grafted neurons become integrated into the host circuitry. The supplement, 20 ng/ml EGF, and 20 ng/ml bFGF, in addition to the results of these analyses should help improve cellular replacement midbrain patterning factors SHH and FGF8. After 2-3 days, the NPC strategies in this model of spinal cord injury and neuroplasticity by accumulated into small aggregates and formed neurospheres. At 7 determining the optimal neuronal phenotypes required for producing days, the number of cells had increased by 1.93-fold. In addition, neuthe observed behavioral gains. rospheres could be passaged and cryopreserved over longer intervals.
Characterization of Cellular Replacement Mediated Modulation
Supported by NIH (5RO1NS54025). Following expansion, the neurospheres were plated on poly-L-lysine/ laminin-coated plates and differentiated in Glasgow minimum essential medium supplemented with 10% knockout serum replacement in CD14 + Human Umbilical Cord Blood Cells Are Essential the presence of SHH, FGF8, and GDNF. After 14 days, MAP2+ and for Neurological Recovery Following MCAO TH+ cells comprised 31 ± 6% and 24 ± 6% of the total cell population, respectively. Approximately 80% of MAP2+ cells expressed TH, T. A. Womble,* S. Green,* P. R. Sanberg,* † K. R. Pennypacker, † while the majority of nonneuronal cells expressed the glial marker and A. E. Willing* GFAP. We further examined whether the expanded NPC could survive transplantation in the form of neurospheres into 6-hydroxydopamine-*Department of Neurosurgery, Center for Aging and Brain Repair, lesioned rat striatum. Recipient rats were euthanized 3 weeks after University of South Florida, Tampa, FL, USA grafting. Brain sections were double labeled using antibodies against †Department of Molecular Pharmacology and Physiology, University human nuclei and TH or the mesencephalic progenitor markers Msx1 of South Florida, Tampa, USA and Otx2. Small numbers of Msx1+ and Otx2 + progenitor cells were identified in the striatum, but TH-expressing neurons were absent. However, in areas of reflux of grafted cells into the cortex, small num-When human umbilical cord blood (HUCB) cells are administered following middle cerebral artery occlusion (MCAO) in the rat, they bers of TH+ neurons were found. Future long-term in vivo experimentation and behavioral studies are required to determine the efficacy induce motor recovery and decrease infarct size. Because few cells are found at the site of injury and alterations in pro-and anti-inflammatory of these neurospheres to generate functional dopaminergic neurons. Derivation and expansion of transplantable human mecencephalic re-cytokines, we believe it is an immune/inflammatory response regulating recovery following HUCB treatment. The HUCB cell preparation stricted NPC, described in the present investigation, is a useful method
